#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Automatic schizophrenic discrimination on fNIRS by using complex brain network analysis and SVM
#Text=Background
#Text=Schizophrenia is a kind of serious mental illness.
1-1	0-9	Automatic	_	
1-2	10-23	schizophrenic	_	
1-3	24-38	discrimination	_	
1-4	39-41	on	_	
1-5	42-47	fNIRS	_	
1-6	48-50	by	_	
1-7	51-56	using	_	
1-8	57-64	complex	_	
1-9	65-70	brain	_	
1-10	71-78	network	_	
1-11	79-87	analysis	_	
1-12	88-91	and	_	
1-13	92-95	SVM	_	
1-14	96-106	Background	_	
1-15	107-120	Schizophrenia	_	
1-16	121-123	is	_	
1-17	124-125	a	_	
1-18	126-130	kind	_	
1-19	131-133	of	_	
1-20	134-141	serious	_	
1-21	142-148	mental	_	
1-22	149-156	illness	_	
1-23	156-157	.	_	

#Text=Due to the lack of an objective physiological data supporting and a unified data analysis method, doctors can only rely on the subjective experience of the data to distinguish normal people and patients, which easily lead to misdiagnosis.
2-1	158-161	Due	_	
2-2	162-164	to	_	
2-3	165-168	the	_	
2-4	169-173	lack	_	
2-5	174-176	of	_	
2-6	177-179	an	_	
2-7	180-189	objective	_	
2-8	190-203	physiological	_	
2-9	204-208	data	_	
2-10	209-219	supporting	_	
2-11	220-223	and	_	
2-12	224-225	a	_	
2-13	226-233	unified	_	
2-14	234-238	data	_	
2-15	239-247	analysis	_	
2-16	248-254	method	_	
2-17	254-255	,	_	
2-18	256-263	doctors	_	
2-19	264-267	can	_	
2-20	268-272	only	_	
2-21	273-277	rely	_	
2-22	278-280	on	_	
2-23	281-284	the	_	
2-24	285-295	subjective	_	
2-25	296-306	experience	_	
2-26	307-309	of	_	
2-27	310-313	the	_	
2-28	314-318	data	_	
2-29	319-321	to	_	
2-30	322-333	distinguish	_	
2-31	334-340	normal	_	
2-32	341-347	people	_	
2-33	348-351	and	_	
2-34	352-360	patients	_	
2-35	360-361	,	_	
2-36	362-367	which	_	
2-37	368-374	easily	_	
2-38	375-379	lead	_	
2-39	380-382	to	_	
2-40	383-395	misdiagnosis	_	
2-41	395-396	.	_	

#Text=In recent years, functional Near-Infrared Spectroscopy (fNIRS) has been widely used in clinical diagnosis, it can get the hemoglobin concentration through the variation of optical intensity.
3-1	397-399	In	_	
3-2	400-406	recent	_	
3-3	407-412	years	_	
3-4	412-413	,	_	
3-5	414-424	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy[1]	
3-6	425-438	Near-Infrared	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy[1]	
3-7	439-451	Spectroscopy	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy[1]	
3-8	452-453	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy[1]	
3-9	453-458	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy[1]	
3-10	458-459	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy[1]	
3-11	460-463	has	_	
3-12	464-468	been	_	
3-13	469-475	widely	_	
3-14	476-480	used	_	
3-15	481-483	in	_	
3-16	484-492	clinical	_	
3-17	493-502	diagnosis	_	
3-18	502-503	,	_	
3-19	504-506	it	_	
3-20	507-510	can	_	
3-21	511-514	get	_	
3-22	515-518	the	_	
3-23	519-529	hemoglobin	_	
3-24	530-543	concentration	_	
3-25	544-551	through	_	
3-26	552-555	the	_	
3-27	556-565	variation	_	
3-28	566-568	of	_	
3-29	569-576	optical	_	
3-30	577-586	intensity	_	
3-31	586-587	.	_	

#Text=Methods
#Text=Firstly, the prefrontal brain networks were constructed based on oxy-Hb signals from 52-channel fNIRS data of schizophrenia and healthy controls.
4-1	588-595	Methods	_	
4-2	596-603	Firstly	_	
4-3	603-604	,	_	
4-4	605-608	the	_	
4-5	609-619	prefrontal	_	
4-6	620-625	brain	_	
4-7	626-634	networks	_	
4-8	635-639	were	_	
4-9	640-651	constructed	_	
4-10	652-657	based	_	
4-11	658-660	on	_	
4-12	661-667	oxy-Hb	_	
4-13	668-675	signals	_	
4-14	676-680	from	_	
4-15	681-683	52	_	
4-16	683-684	-	_	
4-17	684-691	channel	_	
4-18	692-697	fNIRS	_	
4-19	698-702	data	_	
4-20	703-705	of	_	
4-21	706-719	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
4-22	720-723	and	_	
4-23	724-731	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
4-24	732-740	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
4-25	740-741	.	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	

#Text=Then, Complex Brain Network Analysis (CBNA) was used to extract features from the prefrontal brain networks.
5-1	742-746	Then	_	
5-2	746-747	,	_	
5-3	748-755	Complex	_	
5-4	756-761	Brain	_	
5-5	762-769	Network	_	
5-6	770-778	Analysis	_	
5-7	779-780	(	_	
5-8	780-784	CBNA	_	
5-9	784-785	)	_	
5-10	786-789	was	_	
5-11	790-794	used	_	
5-12	795-797	to	_	
5-13	798-805	extract	_	
5-14	806-814	features	_	
5-15	815-819	from	_	
5-16	820-823	the	_	
5-17	824-834	prefrontal	_	
5-18	835-840	brain	_	
5-19	841-849	networks	_	
5-20	849-850	.	_	

#Text=Finally, a classier based on Support Vector Machine (SVM) is designed and trained to discriminate schizophrenia from healthy controls.
6-1	851-858	Finally	_	
6-2	858-859	,	_	
6-3	860-861	a	_	
6-4	862-870	classier	_	
6-5	871-876	based	_	
6-6	877-879	on	_	
6-7	880-887	Support	_	
6-8	888-894	Vector	_	
6-9	895-902	Machine	_	
6-10	903-904	(	_	
6-11	904-907	SVM	_	
6-12	907-908	)	_	
6-13	909-911	is	_	
6-14	912-920	designed	_	
6-15	921-924	and	_	
6-16	925-932	trained	_	
6-17	933-935	to	_	
6-18	936-948	discriminate	_	
6-19	949-962	schizophrenia	_	
6-20	963-967	from	_	
6-21	968-975	healthy	_	
6-22	976-984	controls	_	
6-23	984-985	.	_	

#Text=We recruited a sample which contains 34 healthy controls and 42 schizophrenia patients to do the one-back memory task.
7-1	986-988	We	_	
7-2	989-998	recruited	_	
7-3	999-1000	a	_	
7-4	1001-1007	sample	_	
7-5	1008-1013	which	_	
7-6	1014-1022	contains	_	
7-7	1023-1025	34	_	
7-8	1026-1033	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]	
7-9	1034-1042	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]	
7-10	1043-1046	and	_	
7-11	1047-1049	42	_	
7-12	1050-1063	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[4]	
7-13	1064-1072	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[4]	
7-14	1073-1075	to	_	
7-15	1076-1078	do	_	
7-16	1079-1082	the	_	
7-17	1083-1091	one-back	_	
7-18	1092-1098	memory	_	
7-19	1099-1103	task	_	
7-20	1103-1104	.	_	

#Text=The hemoglobin response was measured in the prefrontal cortex during the task using a 52-channel fNIRS system.
8-1	1105-1108	The	_	
8-2	1109-1119	hemoglobin	_	
8-3	1120-1128	response	_	
8-4	1129-1132	was	_	
8-5	1133-1141	measured	_	
8-6	1142-1144	in	_	
8-7	1145-1148	the	_	
8-8	1149-1159	prefrontal	_	
8-9	1160-1166	cortex	_	
8-10	1167-1173	during	_	
8-11	1174-1177	the	_	
8-12	1178-1182	task	_	
8-13	1183-1188	using	_	
8-14	1189-1190	a	_	
8-15	1191-1193	52	_	
8-16	1193-1194	-	_	
8-17	1194-1201	channel	_	
8-18	1202-1207	fNIRS	_	
8-19	1208-1214	system	_	
8-20	1214-1215	.	_	

#Text=Results
#Text=The experimental results indicate that the proposed method can achieve a satisfactory classification with the accuracy of 85.5%, 92.8% for schizophrenia samples and 76.5% for healthy controls.
9-1	1216-1223	Results	_	
9-2	1224-1227	The	_	
9-3	1228-1240	experimental	_	
9-4	1241-1248	results	_	
9-5	1249-1257	indicate	_	
9-6	1258-1262	that	_	
9-7	1263-1266	the	_	
9-8	1267-1275	proposed	_	
9-9	1276-1282	method	_	
9-10	1283-1286	can	_	
9-11	1287-1294	achieve	_	
9-12	1295-1296	a	_	
9-13	1297-1309	satisfactory	_	
9-14	1310-1324	classification	_	
9-15	1325-1329	with	_	
9-16	1330-1333	the	_	
9-17	1334-1342	accuracy	_	
9-18	1343-1345	of	_	
9-19	1346-1351	85.5%	_	
9-20	1351-1352	,	_	
9-21	1353-1358	92.8%	_	
9-22	1359-1362	for	_	
9-23	1363-1376	schizophrenia	_	
9-24	1377-1384	samples	_	
9-25	1385-1388	and	_	
9-26	1389-1394	76.5%	_	
9-27	1395-1398	for	_	
9-28	1399-1406	healthy	_	
9-29	1407-1415	controls	_	
9-30	1415-1416	.	_	

#Text=Also, our results suggested that fNIRS has the potential capacity to be an effective objective biomarker for the diagnosis of schizophrenia.
10-1	1417-1421	Also	_	
10-2	1421-1422	,	_	
10-3	1423-1426	our	_	
10-4	1427-1434	results	_	
10-5	1435-1444	suggested	_	
10-6	1445-1449	that	_	
10-7	1450-1455	fNIRS	_	
10-8	1456-1459	has	_	
10-9	1460-1463	the	_	
10-10	1464-1473	potential	_	
10-11	1474-1482	capacity	_	
10-12	1483-1485	to	_	
10-13	1486-1488	be	_	
10-14	1489-1491	an	_	
10-15	1492-1501	effective	_	
10-16	1502-1511	objective	_	
10-17	1512-1521	biomarker	_	
10-18	1522-1525	for	_	
10-19	1526-1529	the	_	
10-20	1530-1539	diagnosis	_	
10-21	1540-1542	of	_	
10-22	1543-1556	schizophrenia	_	
10-23	1556-1557	.	_	

#Text=Conclusions
#Text=Our results suggested that, using the appropriate classification method, fNIRS has the potential capacity to be an effective objective biomarker for the diagnosis of schizophrenia.
11-1	1558-1569	Conclusions	_	
11-2	1570-1573	Our	_	
11-3	1574-1581	results	_	
11-4	1582-1591	suggested	_	
11-5	1592-1596	that	_	
11-6	1596-1597	,	_	
11-7	1598-1603	using	_	
11-8	1604-1607	the	_	
11-9	1608-1619	appropriate	_	
11-10	1620-1634	classification	_	
11-11	1635-1641	method	_	
11-12	1641-1642	,	_	
11-13	1643-1648	fNIRS	_	
11-14	1649-1652	has	_	
11-15	1653-1656	the	_	
11-16	1657-1666	potential	_	
11-17	1667-1675	capacity	_	
11-18	1676-1678	to	_	
11-19	1679-1681	be	_	
11-20	1682-1684	an	_	
11-21	1685-1694	effective	_	
11-22	1695-1704	objective	_	
11-23	1705-1714	biomarker	_	
11-24	1715-1718	for	_	
11-25	1719-1722	the	_	
11-26	1723-1732	diagnosis	_	
11-27	1733-1735	of	_	
11-28	1736-1749	schizophrenia	_	
11-29	1749-1750	.	_	

#Text=Background
#Text=Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand what is real.
12-1	1751-1761	Background	_	
12-2	1762-1775	Schizophrenia	_	
12-3	1776-1778	is	_	
12-4	1779-1780	a	_	
12-5	1781-1787	mental	_	
12-6	1788-1796	disorder	_	
12-7	1797-1810	characterized	_	
12-8	1811-1813	by	_	
12-9	1814-1822	abnormal	_	
12-10	1823-1829	social	_	
12-11	1830-1838	behavior	_	
12-12	1839-1842	and	_	
12-13	1843-1850	failure	_	
12-14	1851-1853	to	_	
12-15	1854-1864	understand	_	
12-16	1865-1869	what	_	
12-17	1870-1872	is	_	
12-18	1873-1877	real	_	
12-19	1877-1878	.	_	

#Text=Common symptoms include false beliefs, unclear or confused thinking, hearing voices that others do not hear, reduced social engagement and emotional expression, and a lack of motivation.
13-1	1879-1885	Common	_	
13-2	1886-1894	symptoms	_	
13-3	1895-1902	include	_	
13-4	1903-1908	false	_	
13-5	1909-1916	beliefs	_	
13-6	1916-1917	,	_	
13-7	1918-1925	unclear	_	
13-8	1926-1928	or	_	
13-9	1929-1937	confused	_	
13-10	1938-1946	thinking	_	
13-11	1946-1947	,	_	
13-12	1948-1955	hearing	_	
13-13	1956-1962	voices	_	
13-14	1963-1967	that	_	
13-15	1968-1974	others	_	
13-16	1975-1977	do	_	
13-17	1978-1981	not	_	
13-18	1982-1986	hear	_	
13-19	1986-1987	,	_	
13-20	1988-1995	reduced	_	
13-21	1996-2002	social	_	
13-22	2003-2013	engagement	_	
13-23	2014-2017	and	_	
13-24	2018-2027	emotional	_	
13-25	2028-2038	expression	_	
13-26	2038-2039	,	_	
13-27	2040-2043	and	_	
13-28	2044-2045	a	_	
13-29	2046-2050	lack	_	
13-30	2051-2053	of	_	
13-31	2054-2064	motivation	_	
13-32	2064-2065	.	_	

#Text=It not only produce great pain to the patients but also bring a heavy burden to their family.
#Text=fNIRS is a haemodynamic-based technique for the assessment of functional activity in the human brain.
14-1	2066-2068	It	_	
14-2	2069-2072	not	_	
14-3	2073-2077	only	_	
14-4	2078-2085	produce	_	
14-5	2086-2091	great	_	
14-6	2092-2096	pain	_	
14-7	2097-2099	to	_	
14-8	2100-2103	the	_	
14-9	2104-2112	patients	_	
14-10	2113-2116	but	_	
14-11	2117-2121	also	_	
14-12	2122-2127	bring	_	
14-13	2128-2129	a	_	
14-14	2130-2135	heavy	_	
14-15	2136-2142	burden	_	
14-16	2143-2145	to	_	
14-17	2146-2151	their	_	
14-18	2152-2158	family	_	
14-19	2158-2159	.	_	
14-20	2160-2165	fNIRS	_	
14-21	2166-2168	is	_	
14-22	2169-2170	a	_	
14-23	2171-2189	haemodynamic-based	_	
14-24	2190-2199	technique	_	
14-25	2200-2203	for	_	
14-26	2204-2207	the	_	
14-27	2208-2218	assessment	_	
14-28	2219-2221	of	_	
14-29	2222-2232	functional	_	
14-30	2233-2241	activity	_	
14-31	2242-2244	in	_	
14-32	2245-2248	the	_	
14-33	2249-2254	human	_	
14-34	2255-2260	brain	_	
14-35	2260-2261	.	_	

#Text=Based on the tight coupling of neural activity and oxygen delivery, changes in the concentration of oxygenated and deoxygenated haemoglobin are noninvasively measured by fNIRS and taken as indicators for cortical activation.
15-1	2262-2267	Based	_	
15-2	2268-2270	on	_	
15-3	2271-2274	the	_	
15-4	2275-2280	tight	_	
15-5	2281-2289	coupling	_	
15-6	2290-2292	of	_	
15-7	2293-2299	neural	_	
15-8	2300-2308	activity	_	
15-9	2309-2312	and	_	
15-10	2313-2319	oxygen	_	
15-11	2320-2328	delivery	_	
15-12	2328-2329	,	_	
15-13	2330-2337	changes	_	
15-14	2338-2340	in	_	
15-15	2341-2344	the	_	
15-16	2345-2358	concentration	_	
15-17	2359-2361	of	_	
15-18	2362-2372	oxygenated	_	
15-19	2373-2376	and	_	
15-20	2377-2389	deoxygenated	_	
15-21	2390-2401	haemoglobin	_	
15-22	2402-2405	are	_	
15-23	2406-2419	noninvasively	_	
15-24	2420-2428	measured	_	
15-25	2429-2431	by	_	
15-26	2432-2437	fNIRS	_	
15-27	2438-2441	and	_	
15-28	2442-2447	taken	_	
15-29	2448-2450	as	_	
15-30	2451-2461	indicators	_	
15-31	2462-2465	for	_	
15-32	2466-2474	cortical	_	
15-33	2475-2485	activation	_	
15-34	2485-2486	.	_	

#Text=The typical fNIRS signal observed after neural activation is a decrease of deoxygenated accompanied by an increase of oxygenated comparable in time course to the blood oxygenation level dependent signal of fMRI. fNIRS provides comprehensive information about haemodynamics consisting of oxygenated, deoxygenated and changes in total haemoglobin.
16-1	2487-2490	The	_	
16-2	2491-2498	typical	_	
16-3	2499-2504	fNIRS	_	
16-4	2505-2511	signal	_	
16-5	2512-2520	observed	_	
16-6	2521-2526	after	_	
16-7	2527-2533	neural	_	
16-8	2534-2544	activation	_	
16-9	2545-2547	is	_	
16-10	2548-2549	a	_	
16-11	2550-2558	decrease	_	
16-12	2559-2561	of	_	
16-13	2562-2574	deoxygenated	_	
16-14	2575-2586	accompanied	_	
16-15	2587-2589	by	_	
16-16	2590-2592	an	_	
16-17	2593-2601	increase	_	
16-18	2602-2604	of	_	
16-19	2605-2615	oxygenated	_	
16-20	2616-2626	comparable	_	
16-21	2627-2629	in	_	
16-22	2630-2634	time	_	
16-23	2635-2641	course	_	
16-24	2642-2644	to	_	
16-25	2645-2648	the	_	
16-26	2649-2654	blood	_	
16-27	2655-2666	oxygenation	_	
16-28	2667-2672	level	_	
16-29	2673-2682	dependent	_	
16-30	2683-2689	signal	_	
16-31	2690-2692	of	_	
16-32	2693-2697	fMRI	_	
16-33	2697-2698	.	_	
16-34	2699-2704	fNIRS	_	
16-35	2705-2713	provides	_	
16-36	2714-2727	comprehensive	_	
16-37	2728-2739	information	_	
16-38	2740-2745	about	_	
16-39	2746-2759	haemodynamics	_	
16-40	2760-2770	consisting	_	
16-41	2771-2773	of	_	
16-42	2774-2784	oxygenated	_	
16-43	2784-2785	,	_	
16-44	2786-2798	deoxygenated	_	
16-45	2799-2802	and	_	
16-46	2803-2810	changes	_	
16-47	2811-2813	in	_	
16-48	2814-2819	total	_	
16-49	2820-2831	haemoglobin	_	
16-50	2831-2832	.	_	

#Text=It is characterised by its straightforward application which resembles in the outward appearance more an electroencephalogram.
17-1	2833-2835	It	_	
17-2	2836-2838	is	_	
17-3	2839-2852	characterised	_	
17-4	2853-2855	by	_	
17-5	2856-2859	its	_	
17-6	2860-2875	straightforward	_	
17-7	2876-2887	application	_	
17-8	2888-2893	which	_	
17-9	2894-2903	resembles	_	
17-10	2904-2906	in	_	
17-11	2907-2910	the	_	
17-12	2911-2918	outward	_	
17-13	2919-2929	appearance	_	
17-14	2930-2934	more	_	
17-15	2935-2937	an	_	
17-16	2938-2958	electroencephalogram	_	
17-17	2958-2959	.	_	

#Text=Thus, the data collection is comfortable for the subjects because of the less constrictive measurement circumstances which probably lead to more ecologically valid conditions than in other neuroimaging methods.
18-1	2960-2964	Thus	_	
18-2	2964-2965	,	_	
18-3	2966-2969	the	_	
18-4	2970-2974	data	_	
18-5	2975-2985	collection	_	
18-6	2986-2988	is	_	
18-7	2989-3000	comfortable	_	
18-8	3001-3004	for	_	
18-9	3005-3008	the	_	
18-10	3009-3017	subjects	_	
18-11	3018-3025	because	_	
18-12	3026-3028	of	_	
18-13	3029-3032	the	_	
18-14	3033-3037	less	_	
18-15	3038-3050	constrictive	_	
18-16	3051-3062	measurement	_	
18-17	3063-3076	circumstances	_	
18-18	3077-3082	which	_	
18-19	3083-3091	probably	_	
18-20	3092-3096	lead	_	
18-21	3097-3099	to	_	
18-22	3100-3104	more	_	
18-23	3105-3117	ecologically	_	
18-24	3118-3123	valid	_	
18-25	3124-3134	conditions	_	
18-26	3135-3139	than	_	
18-27	3140-3142	in	_	
18-28	3143-3148	other	_	
18-29	3149-3161	neuroimaging	_	
18-30	3162-3169	methods	_	
18-31	3169-3170	.	_	

#Text=These inherent advantages accompanied by the rapid developments in technology and methodology enabled fNIRS to easily enter psychological, psychiatric and basic research on children, adults and elderly subjects.
19-1	3171-3176	These	_	
19-2	3177-3185	inherent	_	
19-3	3186-3196	advantages	_	
19-4	3197-3208	accompanied	_	
19-5	3209-3211	by	_	
19-6	3212-3215	the	_	
19-7	3216-3221	rapid	_	
19-8	3222-3234	developments	_	
19-9	3235-3237	in	_	
19-10	3238-3248	technology	_	
19-11	3249-3252	and	_	
19-12	3253-3264	methodology	_	
19-13	3265-3272	enabled	_	
19-14	3273-3278	fNIRS	_	
19-15	3279-3281	to	_	
19-16	3282-3288	easily	_	
19-17	3289-3294	enter	_	
19-18	3295-3308	psychological	_	
19-19	3308-3309	,	_	
19-20	3310-3321	psychiatric	_	
19-21	3322-3325	and	_	
19-22	3326-3331	basic	_	
19-23	3332-3340	research	_	
19-24	3341-3343	on	_	
19-25	3344-3352	children	_	
19-26	3352-3353	,	_	
19-27	3354-3360	adults	_	
19-28	3361-3364	and	_	
19-29	3365-3372	elderly	_	
19-30	3373-3381	subjects	_	
19-31	3381-3382	.	_	

#Text=Because the symptom of schizophrenia is similar with other diseases, such as depression and anxiety.
20-1	3383-3390	Because	_	
20-2	3391-3394	the	_	
20-3	3395-3402	symptom	_	
20-4	3403-3405	of	_	
20-5	3406-3419	schizophrenia	_	
20-6	3420-3422	is	_	
20-7	3423-3430	similar	_	
20-8	3431-3435	with	_	
20-9	3436-3441	other	_	
20-10	3442-3450	diseases	_	
20-11	3450-3451	,	_	
20-12	3452-3456	such	_	
20-13	3457-3459	as	_	
20-14	3460-3470	depression	_	
20-15	3471-3474	and	_	
20-16	3475-3482	anxiety	_	
20-17	3482-3483	.	_	

#Text=Doctors can only use the information of genetic predisposition, substance abuse, living conditions and prenatal stressors to predict the schizophrenia is triggered or not.
21-1	3484-3491	Doctors	_	
21-2	3492-3495	can	_	
21-3	3496-3500	only	_	
21-4	3501-3504	use	_	
21-5	3505-3508	the	_	
21-6	3509-3520	information	_	
21-7	3521-3523	of	_	
21-8	3524-3531	genetic	_	
21-9	3532-3546	predisposition	_	
21-10	3546-3547	,	_	
21-11	3548-3557	substance	_	
21-12	3558-3563	abuse	_	
21-13	3563-3564	,	_	
21-14	3565-3571	living	_	
21-15	3572-3582	conditions	_	
21-16	3583-3586	and	_	
21-17	3587-3595	prenatal	_	
21-18	3596-3605	stressors	_	
21-19	3606-3608	to	_	
21-20	3609-3616	predict	_	
21-21	3617-3620	the	_	
21-22	3621-3634	schizophrenia	_	
21-23	3635-3637	is	_	
21-24	3638-3647	triggered	_	
21-25	3648-3650	or	_	
21-26	3651-3654	not	_	
21-27	3654-3655	.	_	

#Text=Usually it is not generate immediately but takes years for the disease to surface.
22-1	3656-3663	Usually	_	
22-2	3664-3666	it	_	
22-3	3667-3669	is	_	
22-4	3670-3673	not	_	
22-5	3674-3682	generate	_	
22-6	3683-3694	immediately	_	
22-7	3695-3698	but	_	
22-8	3699-3704	takes	_	
22-9	3705-3710	years	_	
22-10	3711-3714	for	_	
22-11	3715-3718	the	_	
22-12	3719-3726	disease	_	
22-13	3727-3729	to	_	
22-14	3730-3737	surface	_	
22-15	3737-3738	.	_	

#Text=So design a computer aided identification method can help improving the doctor’s diagnostic result.
23-1	3739-3741	So	_	
23-2	3742-3748	design	_	
23-3	3749-3750	a	_	
23-4	3751-3759	computer	_	
23-5	3760-3765	aided	_	
23-6	3766-3780	identification	_	
23-7	3781-3787	method	_	
23-8	3788-3791	can	_	
23-9	3792-3796	help	_	
23-10	3797-3806	improving	_	
23-11	3807-3810	the	_	
23-12	3811-3817	doctor	_	
23-13	3817-3818	’	_	
23-14	3818-3819	s	_	
23-15	3820-3830	diagnostic	_	
23-16	3831-3837	result	_	
23-17	3837-3838	.	_	

#Text=With that being the case, many patients can have access to a proper medication, as such, the wellbeing of the patients and the medical quality of hospitals will increase.
24-1	3839-3843	With	_	
24-2	3844-3848	that	_	
24-3	3849-3854	being	_	
24-4	3855-3858	the	_	
24-5	3859-3863	case	_	
24-6	3863-3864	,	_	
24-7	3865-3869	many	_	
24-8	3870-3878	patients	_	
24-9	3879-3882	can	_	
24-10	3883-3887	have	_	
24-11	3888-3894	access	_	
24-12	3895-3897	to	_	
24-13	3898-3899	a	_	
24-14	3900-3906	proper	_	
24-15	3907-3917	medication	_	
24-16	3917-3918	,	_	
24-17	3919-3921	as	_	
24-18	3922-3926	such	_	
24-19	3926-3927	,	_	
24-20	3928-3931	the	_	
24-21	3932-3941	wellbeing	_	
24-22	3942-3944	of	_	
24-23	3945-3948	the	_	
24-24	3949-3957	patients	_	
24-25	3958-3961	and	_	
24-26	3962-3965	the	_	
24-27	3966-3973	medical	_	
24-28	3974-3981	quality	_	
24-29	3982-3984	of	_	
24-30	3985-3994	hospitals	_	
24-31	3995-3999	will	_	
24-32	4000-4008	increase	_	
24-33	4008-4009	.	_	

#Text=During the past several years, many studies have applied the fNIRS technique to investigate the brain activation patterns in patients with schizophrenia.
25-1	4010-4016	During	_	
25-2	4017-4020	the	_	
25-3	4021-4025	past	_	
25-4	4026-4033	several	_	
25-5	4034-4039	years	_	
25-6	4039-4040	,	_	
25-7	4041-4045	many	_	
25-8	4046-4053	studies	_	
25-9	4054-4058	have	_	
25-10	4059-4066	applied	_	
25-11	4067-4070	the	_	
25-12	4071-4076	fNIRS	_	
25-13	4077-4086	technique	_	
25-14	4087-4089	to	_	
25-15	4090-4101	investigate	_	
25-16	4102-4105	the	_	
25-17	4106-4111	brain	_	
25-18	4112-4122	activation	_	
25-19	4123-4131	patterns	_	
25-20	4132-4134	in	_	
25-21	4135-4143	patients	_	
25-22	4144-4148	with	_	
25-23	4149-4162	schizophrenia	_	
25-24	4162-4163	.	_	

#Text=Converging evidence suggests schizophrenia patients are often associated with reduced activities and inappropriate activity timing around the bilateral prefrontal cortex during a verbal fluency task or other cognitive tasks.
26-1	4164-4174	Converging	_	
26-2	4175-4183	evidence	_	
26-3	4184-4192	suggests	_	
26-4	4193-4206	schizophrenia	_	
26-5	4207-4215	patients	_	
26-6	4216-4219	are	_	
26-7	4220-4225	often	_	
26-8	4226-4236	associated	_	
26-9	4237-4241	with	_	
26-10	4242-4249	reduced	_	
26-11	4250-4260	activities	_	
26-12	4261-4264	and	_	
26-13	4265-4278	inappropriate	_	
26-14	4279-4287	activity	_	
26-15	4288-4294	timing	_	
26-16	4295-4301	around	_	
26-17	4302-4305	the	_	
26-18	4306-4315	bilateral	_	
26-19	4316-4326	prefrontal	_	
26-20	4327-4333	cortex	_	
26-21	4334-4340	during	_	
26-22	4341-4342	a	_	
26-23	4343-4349	verbal	_	
26-24	4350-4357	fluency	_	
26-25	4358-4362	task	_	
26-26	4363-4365	or	_	
26-27	4366-4371	other	_	
26-28	4372-4381	cognitive	_	
26-29	4382-4387	tasks	_	
26-30	4387-4388	.	_	

#Text=Based on these findings, some studies have attempted to apply the fNIRS signal as a diagnostic tool with different pattern recognition methods.
27-1	4389-4394	Based	_	
27-2	4395-4397	on	_	
27-3	4398-4403	these	_	
27-4	4404-4412	findings	_	
27-5	4412-4413	,	_	
27-6	4414-4418	some	_	
27-7	4419-4426	studies	_	
27-8	4427-4431	have	_	
27-9	4432-4441	attempted	_	
27-10	4442-4444	to	_	
27-11	4445-4450	apply	_	
27-12	4451-4454	the	_	
27-13	4455-4460	fNIRS	_	
27-14	4461-4467	signal	_	
27-15	4468-4470	as	_	
27-16	4471-4472	a	_	
27-17	4473-4483	diagnostic	_	
27-18	4484-4488	tool	_	
27-19	4489-4493	with	_	
27-20	4494-4503	different	_	
27-21	4504-4511	pattern	_	
27-22	4512-4523	recognition	_	
27-23	4524-4531	methods	_	
27-24	4531-4532	.	_	

#Text=In, authors measured the changes of the oxy-Hb signal during multiple cognitive tasks from two fNIRS channels located in the bilateral prefrontal areas and then applied stepwise linear discriminant analysis to distinguish patients with schizophrenia from healthy subjects.
28-1	4533-4535	In	_	
28-2	4535-4536	,	_	
28-3	4537-4544	authors	_	
28-4	4545-4553	measured	_	
28-5	4554-4557	the	_	
28-6	4558-4565	changes	_	
28-7	4566-4568	of	_	
28-8	4569-4572	the	_	
28-9	4573-4579	oxy-Hb	_	
28-10	4580-4586	signal	_	
28-11	4587-4593	during	_	
28-12	4594-4602	multiple	_	
28-13	4603-4612	cognitive	_	
28-14	4613-4618	tasks	_	
28-15	4619-4623	from	_	
28-16	4624-4627	two	_	
28-17	4628-4633	fNIRS	_	
28-18	4634-4642	channels	_	
28-19	4643-4650	located	_	
28-20	4651-4653	in	_	
28-21	4654-4657	the	_	
28-22	4658-4667	bilateral	_	
28-23	4668-4678	prefrontal	_	
28-24	4679-4684	areas	_	
28-25	4685-4688	and	_	
28-26	4689-4693	then	_	
28-27	4694-4701	applied	_	
28-28	4702-4710	stepwise	_	
28-29	4711-4717	linear	_	
28-30	4718-4730	discriminant	_	
28-31	4731-4739	analysis	_	
28-32	4740-4742	to	_	
28-33	4743-4754	distinguish	_	
28-34	4755-4763	patients	_	
28-35	4764-4768	with	_	
28-36	4769-4782	schizophrenia	_	
28-37	4783-4787	from	_	
28-38	4788-4795	healthy	_	
28-39	4796-4804	subjects	_	
28-40	4804-4805	.	_	

#Text=They separated the total sample into two groups, and each group consisted of 60 subjects (including 30 patients with schizophrenia and 30 age-and gender-matched healthy controls).
29-1	4806-4810	They	_	
29-2	4811-4820	separated	_	
29-3	4821-4824	the	_	
29-4	4825-4830	total	_	
29-5	4831-4837	sample	_	
29-6	4838-4842	into	_	
29-7	4843-4846	two	_	
29-8	4847-4853	groups	_	
29-9	4853-4854	,	_	
29-10	4855-4858	and	_	
29-11	4859-4863	each	_	
29-12	4864-4869	group	_	
29-13	4870-4879	consisted	_	
29-14	4880-4882	of	_	
29-15	4883-4885	60	_	
29-16	4886-4894	subjects	_	
29-17	4895-4896	(	_	
29-18	4896-4905	including	_	
29-19	4906-4908	30	_	
29-20	4909-4917	patients	_	
29-21	4918-4922	with	_	
29-22	4923-4936	schizophrenia	_	
29-23	4937-4940	and	_	
29-24	4941-4943	30	_	
29-25	4944-4951	age-and	_	
29-26	4952-4966	gender-matched	_	
29-27	4967-4974	healthy	_	
29-28	4975-4983	controls	_	
29-29	4983-4984	)	_	
29-30	4984-4985	.	_	

#Text=The experimental results demonstrated that there was an accuracy rate of 88.3% for classification in the first group, and the discrimination function derived from the first group correctly differentiated 75% of the subjects in the second group.
30-1	4986-4989	The	_	
30-2	4990-5002	experimental	_	
30-3	5003-5010	results	_	
30-4	5011-5023	demonstrated	_	
30-5	5024-5028	that	_	
30-6	5029-5034	there	_	
30-7	5035-5038	was	_	
30-8	5039-5041	an	_	
30-9	5042-5050	accuracy	_	
30-10	5051-5055	rate	_	
30-11	5056-5058	of	_	
30-12	5059-5064	88.3%	_	
30-13	5065-5068	for	_	
30-14	5069-5083	classification	_	
30-15	5084-5086	in	_	
30-16	5087-5090	the	_	
30-17	5091-5096	first	_	
30-18	5097-5102	group	_	
30-19	5102-5103	,	_	
30-20	5104-5107	and	_	
30-21	5108-5111	the	_	
30-22	5112-5126	discrimination	_	
30-23	5127-5135	function	_	
30-24	5136-5143	derived	_	
30-25	5144-5148	from	_	
30-26	5149-5152	the	_	
30-27	5153-5158	first	_	
30-28	5159-5164	group	_	
30-29	5165-5174	correctly	_	
30-30	5175-5189	differentiated	_	
30-31	5190-5193	75%	_	
30-32	5194-5196	of	_	
30-33	5197-5200	the	_	
30-34	5201-5209	subjects	_	
30-35	5210-5212	in	_	
30-36	5213-5216	the	_	
30-37	5217-5223	second	_	
30-38	5224-5229	group	_	
30-39	5229-5230	.	_	

#Text=To integrate spatial and temporal information in multichannel fNIRS, employed a novel probabilistic pattern recognition method called Gaussian process classifier for the diagnostic classification of schizophrenia.
31-1	5231-5233	To	_	
31-2	5234-5243	integrate	_	
31-3	5244-5251	spatial	_	
31-4	5252-5255	and	_	
31-5	5256-5264	temporal	_	
31-6	5265-5276	information	_	
31-7	5277-5279	in	_	
31-8	5280-5292	multichannel	_	
31-9	5293-5298	fNIRS	_	
31-10	5298-5299	,	_	
31-11	5300-5308	employed	_	
31-12	5309-5310	a	_	
31-13	5311-5316	novel	_	
31-14	5317-5330	probabilistic	_	
31-15	5331-5338	pattern	_	
31-16	5339-5350	recognition	_	
31-17	5351-5357	method	_	
31-18	5358-5364	called	_	
31-19	5365-5373	Gaussian	_	
31-20	5374-5381	process	_	
31-21	5382-5392	classifier	_	
31-22	5393-5396	for	_	
31-23	5397-5400	the	_	
31-24	5401-5411	diagnostic	_	
31-25	5412-5426	classification	_	
31-26	5427-5429	of	_	
31-27	5430-5443	schizophrenia	_	
31-28	5443-5444	.	_	

#Text=Using the temporal patterns of fNIRS data measured during a working memory task, an overall accuracy of 76% was achieved in a group of 80 samples.
32-1	5445-5450	Using	_	
32-2	5451-5454	the	_	
32-3	5455-5463	temporal	_	
32-4	5464-5472	patterns	_	
32-5	5473-5475	of	_	
32-6	5476-5481	fNIRS	_	
32-7	5482-5486	data	_	
32-8	5487-5495	measured	_	
32-9	5496-5502	during	_	
32-10	5503-5504	a	_	
32-11	5505-5512	working	_	
32-12	5513-5519	memory	_	
32-13	5520-5524	task	_	
32-14	5524-5525	,	_	
32-15	5526-5528	an	_	
32-16	5529-5536	overall	_	
32-17	5537-5545	accuracy	_	
32-18	5546-5548	of	_	
32-19	5549-5552	76%	_	
32-20	5553-5556	was	_	
32-21	5557-5565	achieved	_	
32-22	5566-5568	in	_	
32-23	5569-5570	a	_	
32-24	5571-5576	group	_	
32-25	5577-5579	of	_	
32-26	5580-5582	80	_	
32-27	5583-5590	samples	_	
32-28	5590-5591	.	_	

#Text=And applied a 52 channel fNIRS system to identify the significantly different regions in the prefrontal cortex during a verbal fluency test and then utilized a k-means clustering method for discriminant analysis between schizophrenia patients and healthy subjects.
33-1	5592-5595	And	_	
33-2	5596-5603	applied	_	
33-3	5604-5605	a	_	
33-4	5606-5608	52	_	
33-5	5609-5616	channel	_	
33-6	5617-5622	fNIRS	_	
33-7	5623-5629	system	_	
33-8	5630-5632	to	_	
33-9	5633-5641	identify	_	
33-10	5642-5645	the	_	
33-11	5646-5659	significantly	_	
33-12	5660-5669	different	_	
33-13	5670-5677	regions	_	
33-14	5678-5680	in	_	
33-15	5681-5684	the	_	
33-16	5685-5695	prefrontal	_	
33-17	5696-5702	cortex	_	
33-18	5703-5709	during	_	
33-19	5710-5711	a	_	
33-20	5712-5718	verbal	_	
33-21	5719-5726	fluency	_	
33-22	5727-5731	test	_	
33-23	5732-5735	and	_	
33-24	5736-5740	then	_	
33-25	5741-5749	utilized	_	
33-26	5750-5751	a	_	
33-27	5752-5759	k-means	_	
33-28	5760-5770	clustering	_	
33-29	5771-5777	method	_	
33-30	5778-5781	for	_	
33-31	5782-5794	discriminant	_	
33-32	5795-5803	analysis	_	
33-33	5804-5811	between	_	
33-34	5812-5825	schizophrenia	_	
33-35	5826-5834	patients	_	
33-36	5835-5838	and	_	
33-37	5839-5846	healthy	_	
33-38	5847-5855	subjects	_	
33-39	5855-5856	.	_	

#Text=The results indicated 68.69% and 71.72% of the participants were correctly classified as schizophrenic or healthy subjects with all 52 channels and six significantly different channels, respectively.
34-1	5857-5860	The	_	
34-2	5861-5868	results	_	
34-3	5869-5878	indicated	_	
34-4	5879-5885	68.69%	_	
34-5	5886-5889	and	_	
34-6	5890-5896	71.72%	_	
34-7	5897-5899	of	_	
34-8	5900-5903	the	_	
34-9	5904-5916	participants	_	
34-10	5917-5921	were	_	
34-11	5922-5931	correctly	_	
34-12	5932-5942	classified	_	
34-13	5943-5945	as	_	
34-14	5946-5959	schizophrenic	_	
34-15	5960-5962	or	_	
34-16	5963-5970	healthy	_	
34-17	5971-5979	subjects	_	
34-18	5980-5984	with	_	
34-19	5985-5988	all	_	
34-20	5989-5991	52	_	
34-21	5992-6000	channels	_	
34-22	6001-6004	and	_	
34-23	6005-6008	six	_	
34-24	6009-6022	significantly	_	
34-25	6023-6032	different	_	
34-26	6033-6041	channels	_	
34-27	6041-6042	,	_	
34-28	6043-6055	respectively	_	
34-29	6055-6056	.	_	

#Text=And proposed a method using principal component analysis and SVM to discriminate patients with schizophrenia from health controls using a large sample of 52 schizophrenia patients and 38 healthy controls.
35-1	6057-6060	And	_	
35-2	6061-6069	proposed	_	
35-3	6070-6071	a	_	
35-4	6072-6078	method	_	
35-5	6079-6084	using	_	
35-6	6085-6094	principal	_	
35-7	6095-6104	component	_	
35-8	6105-6113	analysis	_	
35-9	6114-6117	and	_	
35-10	6118-6121	SVM	_	
35-11	6122-6124	to	_	
35-12	6125-6137	discriminate	_	
35-13	6138-6146	patients	_	
35-14	6147-6151	with	_	
35-15	6152-6165	schizophrenia	_	
35-16	6166-6170	from	_	
35-17	6171-6177	health	_	
35-18	6178-6186	controls	_	
35-19	6187-6192	using	_	
35-20	6193-6194	a	_	
35-21	6195-6200	large	_	
35-22	6201-6207	sample	_	
35-23	6208-6210	of	_	
35-24	6211-6213	52	_	
35-25	6214-6227	schizophrenia	_	
35-26	6228-6236	patients	_	
35-27	6237-6240	and	_	
35-28	6241-6243	38	_	
35-29	6244-6251	healthy	_	
35-30	6252-6260	controls	_	
35-31	6260-6261	.	_	

#Text=They achieved a satisfactory classification with the accuracy of 93.33%, 100% for schizophrenia samples and 84.62% for healthy controls.
36-1	6262-6266	They	_	
36-2	6267-6275	achieved	_	
36-3	6276-6277	a	_	
36-4	6278-6290	satisfactory	_	
36-5	6291-6305	classification	_	
36-6	6306-6310	with	_	
36-7	6311-6314	the	_	
36-8	6315-6323	accuracy	_	
36-9	6324-6326	of	_	
36-10	6327-6333	93.33%	_	
36-11	6333-6334	,	_	
36-12	6335-6339	100%	_	
36-13	6340-6343	for	_	
36-14	6344-6357	schizophrenia	_	
36-15	6358-6365	samples	_	
36-16	6366-6369	and	_	
36-17	6370-6376	84.62%	_	
36-18	6377-6380	for	_	
36-19	6381-6388	healthy	_	
36-20	6389-6397	controls	_	
36-21	6397-6398	.	_	

#Text=Human brain network is one of the complex networks.
37-1	6399-6404	Human	_	
37-2	6405-6410	brain	_	
37-3	6411-6418	network	_	
37-4	6419-6421	is	_	
37-5	6422-6425	one	_	
37-6	6426-6428	of	_	
37-7	6429-6432	the	_	
37-8	6433-6440	complex	_	
37-9	6441-6449	networks	_	
37-10	6449-6450	.	_	

#Text=Researchers have used the complex network theory to construct the brain network, then analyze the constructed brain network using complex network theory and calculate index of the brain network for further study.
38-1	6451-6462	Researchers	_	
38-2	6463-6467	have	_	
38-3	6468-6472	used	_	
38-4	6473-6476	the	_	
38-5	6477-6484	complex	_	
38-6	6485-6492	network	_	
38-7	6493-6499	theory	_	
38-8	6500-6502	to	_	
38-9	6503-6512	construct	_	
38-10	6513-6516	the	_	
38-11	6517-6522	brain	_	
38-12	6523-6530	network	_	
38-13	6530-6531	,	_	
38-14	6532-6536	then	_	
38-15	6537-6544	analyze	_	
38-16	6545-6548	the	_	
38-17	6549-6560	constructed	_	
38-18	6561-6566	brain	_	
38-19	6567-6574	network	_	
38-20	6575-6580	using	_	
38-21	6581-6588	complex	_	
38-22	6589-6596	network	_	
38-23	6597-6603	theory	_	
38-24	6604-6607	and	_	
38-25	6608-6617	calculate	_	
38-26	6618-6623	index	_	
38-27	6624-6626	of	_	
38-28	6627-6630	the	_	
38-29	6631-6636	brain	_	
38-30	6637-6644	network	_	
38-31	6645-6648	for	_	
38-32	6649-6656	further	_	
38-33	6657-6662	study	_	
38-34	6662-6663	.	_	

#Text=The brain network can be divided into structural and functional brain network.
39-1	6664-6667	The	_	
39-2	6668-6673	brain	_	
39-3	6674-6681	network	_	
39-4	6682-6685	can	_	
39-5	6686-6688	be	_	
39-6	6689-6696	divided	_	
39-7	6697-6701	into	_	
39-8	6702-6712	structural	_	
39-9	6713-6716	and	_	
39-10	6717-6727	functional	_	
39-11	6728-6733	brain	_	
39-12	6734-6741	network	_	
39-13	6741-6742	.	_	

#Text=The nodes and edges are two key elements in the brain network.
40-1	6743-6746	The	_	
40-2	6747-6752	nodes	_	
40-3	6753-6756	and	_	
40-4	6757-6762	edges	_	
40-5	6763-6766	are	_	
40-6	6767-6770	two	_	
40-7	6771-6774	key	_	
40-8	6775-6783	elements	_	
40-9	6784-6786	in	_	
40-10	6787-6790	the	_	
40-11	6791-6796	brain	_	
40-12	6797-6804	network	_	
40-13	6804-6805	.	_	

#Text=Diffusion tensor imaging and diffusion spectrum imaging are two imaging techniques used in structural brain network.
41-1	6806-6815	Diffusion	_	
41-2	6816-6822	tensor	_	
41-3	6823-6830	imaging	_	
41-4	6831-6834	and	_	
41-5	6835-6844	diffusion	_	
41-6	6845-6853	spectrum	_	
41-7	6854-6861	imaging	_	
41-8	6862-6865	are	_	
41-9	6866-6869	two	_	
41-10	6870-6877	imaging	_	
41-11	6878-6888	techniques	_	
41-12	6889-6893	used	_	
41-13	6894-6896	in	_	
41-14	6897-6907	structural	_	
41-15	6908-6913	brain	_	
41-16	6914-6921	network	_	
41-17	6921-6922	.	_	

#Text=Since the two techniques can track the direction of the mental fiber electrical signal, the structural brain network is considered as directional.
42-1	6923-6928	Since	_	
42-2	6929-6932	the	_	
42-3	6933-6936	two	_	
42-4	6937-6947	techniques	_	
42-5	6948-6951	can	_	
42-6	6952-6957	track	_	
42-7	6958-6961	the	_	
42-8	6962-6971	direction	_	
42-9	6972-6974	of	_	
42-10	6975-6978	the	_	
42-11	6979-6985	mental	_	
42-12	6986-6991	fiber	_	
42-13	6992-7002	electrical	_	
42-14	7003-7009	signal	_	
42-15	7009-7010	,	_	
42-16	7011-7014	the	_	
42-17	7015-7025	structural	_	
42-18	7026-7031	brain	_	
42-19	7032-7039	network	_	
42-20	7040-7042	is	_	
42-21	7043-7053	considered	_	
42-22	7054-7056	as	_	
42-23	7057-7068	directional	_	
42-24	7068-7069	.	_	

#Text=The definition of the node of functional brain network is changing with different imaging techniques.
43-1	7070-7073	The	_	
43-2	7074-7084	definition	_	
43-3	7085-7087	of	_	
43-4	7088-7091	the	_	
43-5	7092-7096	node	_	
43-6	7097-7099	of	_	
43-7	7100-7110	functional	_	
43-8	7111-7116	brain	_	
43-9	7117-7124	network	_	
43-10	7125-7127	is	_	
43-11	7128-7136	changing	_	
43-12	7137-7141	with	_	
43-13	7142-7151	different	_	
43-14	7152-7159	imaging	_	
43-15	7160-7170	techniques	_	
43-16	7170-7171	.	_	

#Text=Generally we define the connections between nodes by calculating pearson correlation or partial correlation which is used to describe the statistical significance of functional brain signals over a period of time.
44-1	7172-7181	Generally	_	
44-2	7182-7184	we	_	
44-3	7185-7191	define	_	
44-4	7192-7195	the	_	
44-5	7196-7207	connections	_	
44-6	7208-7215	between	_	
44-7	7216-7221	nodes	_	
44-8	7222-7224	by	_	
44-9	7225-7236	calculating	_	
44-10	7237-7244	pearson	_	
44-11	7245-7256	correlation	_	
44-12	7257-7259	or	_	
44-13	7260-7267	partial	_	
44-14	7268-7279	correlation	_	
44-15	7280-7285	which	_	
44-16	7286-7288	is	_	
44-17	7289-7293	used	_	
44-18	7294-7296	to	_	
44-19	7297-7305	describe	_	
44-20	7306-7309	the	_	
44-21	7310-7321	statistical	_	
44-22	7322-7334	significance	_	
44-23	7335-7337	of	_	
44-24	7338-7348	functional	_	
44-25	7349-7354	brain	_	
44-26	7355-7362	signals	_	
44-27	7363-7367	over	_	
44-28	7368-7369	a	_	
44-29	7370-7376	period	_	
44-30	7377-7379	of	_	
44-31	7380-7384	time	_	
44-32	7384-7385	.	_	

#Text=The functional network is non-directional since the correlation between nodes only reflects their statistical significance, no causal relationship.
45-1	7386-7389	The	_	
45-2	7390-7400	functional	_	
45-3	7401-7408	network	_	
45-4	7409-7411	is	_	
45-5	7412-7427	non-directional	_	
45-6	7428-7433	since	_	
45-7	7434-7437	the	_	
45-8	7438-7449	correlation	_	
45-9	7450-7457	between	_	
45-10	7458-7463	nodes	_	
45-11	7464-7468	only	_	
45-12	7469-7477	reflects	_	
45-13	7478-7483	their	_	
45-14	7484-7495	statistical	_	
45-15	7496-7508	significance	_	
45-16	7508-7509	,	_	
45-17	7510-7512	no	_	
45-18	7513-7519	causal	_	
45-19	7520-7532	relationship	_	
45-20	7532-7533	.	_	

#Text=In this paper, we designed a cognitive task and recruited a group of subjects to perform this task.
46-1	7534-7536	In	_	
46-2	7537-7541	this	_	
46-3	7542-7547	paper	_	
46-4	7547-7548	,	_	
46-5	7549-7551	we	_	
46-6	7552-7560	designed	_	
46-7	7561-7562	a	_	
46-8	7563-7572	cognitive	_	
46-9	7573-7577	task	_	
46-10	7578-7581	and	_	
46-11	7582-7591	recruited	_	
46-12	7592-7593	a	_	
46-13	7594-7599	group	_	
46-14	7600-7602	of	_	
46-15	7603-7611	subjects	_	
46-16	7612-7614	to	_	
46-17	7615-7622	perform	_	
46-18	7623-7627	this	_	
46-19	7628-7632	task	_	
46-20	7632-7633	.	_	

#Text=The group included 42 schizophrenia patients and 34 healthy controls and a 52 multichannel fNIRS system was used to examine the hemodynamic signals in the bilateral prefrontal and superior temporal cortices during the cognitive task.
47-1	7634-7637	The	_	
47-2	7638-7643	group	_	
47-3	7644-7652	included	_	
47-4	7653-7655	42	_	
47-5	7656-7669	schizophrenia	_	
47-6	7670-7678	patients	_	
47-7	7679-7682	and	_	
47-8	7683-7685	34	_	
47-9	7686-7693	healthy	_	
47-10	7694-7702	controls	_	
47-11	7703-7706	and	_	
47-12	7707-7708	a	_	
47-13	7709-7711	52	_	
47-14	7712-7724	multichannel	_	
47-15	7725-7730	fNIRS	_	
47-16	7731-7737	system	_	
47-17	7738-7741	was	_	
47-18	7742-7746	used	_	
47-19	7747-7749	to	_	
47-20	7750-7757	examine	_	
47-21	7758-7761	the	_	
47-22	7762-7773	hemodynamic	_	
47-23	7774-7781	signals	_	
47-24	7782-7784	in	_	
47-25	7785-7788	the	_	
47-26	7789-7798	bilateral	_	
47-27	7799-7809	prefrontal	_	
47-28	7810-7813	and	_	
47-29	7814-7822	superior	_	
47-30	7823-7831	temporal	_	
47-31	7832-7840	cortices	_	
47-32	7841-7847	during	_	
47-33	7848-7851	the	_	
47-34	7852-7861	cognitive	_	
47-35	7862-7866	task	_	
47-36	7866-7867	.	_	

#Text=Then we used CBNA to extract the effective features between schizophrenia patients and healthy controls.
48-1	7868-7872	Then	_	
48-2	7873-7875	we	_	
48-3	7876-7880	used	_	
48-4	7881-7885	CBNA	_	
48-5	7886-7888	to	_	
48-6	7889-7896	extract	_	
48-7	7897-7900	the	_	
48-8	7901-7910	effective	_	
48-9	7911-7919	features	_	
48-10	7920-7927	between	_	
48-11	7928-7941	schizophrenia	_	
48-12	7942-7950	patients	_	
48-13	7951-7954	and	_	
48-14	7955-7962	healthy	_	
48-15	7963-7971	controls	_	
48-16	7971-7972	.	_	

#Text=Finally we trained the SVM classifier and evaluated it with leave-one-out cross validation.
49-1	7973-7980	Finally	_	
49-2	7981-7983	we	_	
49-3	7984-7991	trained	_	
49-4	7992-7995	the	_	
49-5	7996-7999	SVM	_	
49-6	8000-8010	classifier	_	
49-7	8011-8014	and	_	
49-8	8015-8024	evaluated	_	
49-9	8025-8027	it	_	
49-10	8028-8032	with	_	
49-11	8033-8046	leave-one-out	_	
49-12	8047-8052	cross	_	
49-13	8053-8063	validation	_	
49-14	8063-8064	.	_	

#Text=The results show that the proposed approach has the high potential to be a promising clinical tool in the objective diagnosis and treatment of psychiatric disorders.
50-1	8065-8068	The	_	
50-2	8069-8076	results	_	
50-3	8077-8081	show	_	
50-4	8082-8086	that	_	
50-5	8087-8090	the	_	
50-6	8091-8099	proposed	_	
50-7	8100-8108	approach	_	
50-8	8109-8112	has	_	
50-9	8113-8116	the	_	
50-10	8117-8121	high	_	
50-11	8122-8131	potential	_	
50-12	8132-8134	to	_	
50-13	8135-8137	be	_	
50-14	8138-8139	a	_	
50-15	8140-8149	promising	_	
50-16	8150-8158	clinical	_	
50-17	8159-8163	tool	_	
50-18	8164-8166	in	_	
50-19	8167-8170	the	_	
50-20	8171-8180	objective	_	
50-21	8181-8190	diagnosis	_	
50-22	8191-8194	and	_	
50-23	8195-8204	treatment	_	
50-24	8205-8207	of	_	
50-25	8208-8219	psychiatric	_	
50-26	8220-8229	disorders	_	
50-27	8229-8230	.	_	

#Text=Methods
#Text=DataSet description
#Text=Ten to twenty system channel map for the 52 channels
#Text=The dataset was provided by Peking University Sixth Hospital.
51-1	8231-8238	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod	
51-2	8239-8246	DataSet	_	
51-3	8247-8258	description	_	
51-4	8259-8262	Ten	_	
51-5	8263-8265	to	_	
51-6	8266-8272	twenty	_	
51-7	8273-8279	system	_	
51-8	8280-8287	channel	_	
51-9	8288-8291	map	_	
51-10	8292-8295	for	_	
51-11	8296-8299	the	_	
51-12	8300-8302	52	_	
51-13	8303-8311	channels	_	
51-14	8312-8315	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
51-15	8316-8323	dataset	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
51-16	8324-8327	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
51-17	8328-8336	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
51-18	8337-8339	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
51-19	8340-8346	Peking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
51-20	8347-8357	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
51-21	8358-8363	Sixth	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
51-22	8364-8372	Hospital	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
51-23	8372-8373	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	

#Text=The fNIRS measurements were conducted with a 52 multichannel fNIRS System (ETG-4000, Hitachi Medical Co., Japan).
52-1	8374-8377	The	_	
52-2	8378-8383	fNIRS	_	
52-3	8384-8396	measurements	_	
52-4	8397-8401	were	_	
52-5	8402-8411	conducted	_	
52-6	8412-8416	with	_	
52-7	8417-8418	a	_	
52-8	8419-8421	52	_	
52-9	8422-8434	multichannel	_	
52-10	8435-8440	fNIRS	_	
52-11	8441-8447	System	_	
52-12	8448-8449	(	_	
52-13	8449-8452	ETG	_	
52-14	8452-8453	-	_	
52-15	8453-8457	4000	_	
52-16	8457-8458	,	_	
52-17	8459-8466	Hitachi	_	
52-18	8467-8474	Medical	_	
52-19	8475-8477	Co	_	
52-20	8477-8478	.	_	
52-21	8478-8479	,	_	
52-22	8480-8485	Japan	_	
52-23	8485-8486	)	_	
52-24	8486-8487	.	_	

#Text=In the system, 33 probes (17 emitters and 16 detectors) were stabilized on the scalp and arranged as a 3 × 11 array, which was positioned according to the international 10–20 system.
53-1	8488-8490	In	_	
53-2	8491-8494	the	_	
53-3	8495-8501	system	_	
53-4	8501-8502	,	_	
53-5	8503-8505	33	_	
53-6	8506-8512	probes	_	
53-7	8513-8514	(	_	
53-8	8514-8516	17	_	
53-9	8517-8525	emitters	_	
53-10	8526-8529	and	_	
53-11	8530-8532	16	_	
53-12	8533-8542	detectors	_	
53-13	8542-8543	)	_	
53-14	8544-8548	were	_	
53-15	8549-8559	stabilized	_	
53-16	8560-8562	on	_	
53-17	8563-8566	the	_	
53-18	8567-8572	scalp	_	
53-19	8573-8576	and	_	
53-20	8577-8585	arranged	_	
53-21	8586-8588	as	_	
53-22	8589-8590	a	_	
53-23	8591-8592	3	_	
53-24	8593-8594	×	_	
53-25	8595-8597	11	_	
53-26	8598-8603	array	_	
53-27	8603-8604	,	_	
53-28	8605-8610	which	_	
53-29	8611-8614	was	_	
53-30	8615-8625	positioned	_	
53-31	8626-8635	according	_	
53-32	8636-8638	to	_	
53-33	8639-8642	the	_	
53-34	8643-8656	international	_	
53-35	8657-8659	10	_	
53-36	8659-8660	–	_	
53-37	8660-8662	20	_	
53-38	8663-8669	system	_	
53-39	8669-8670	.	_	

#Text=The recording channels were established between each pair of emitters and detectors, which resulted in 52 channels total.
54-1	8671-8674	The	_	
54-2	8675-8684	recording	_	
54-3	8685-8693	channels	_	
54-4	8694-8698	were	_	
54-5	8699-8710	established	_	
54-6	8711-8718	between	_	
54-7	8719-8723	each	_	
54-8	8724-8728	pair	_	
54-9	8729-8731	of	_	
54-10	8732-8740	emitters	_	
54-11	8741-8744	and	_	
54-12	8745-8754	detectors	_	
54-13	8754-8755	,	_	
54-14	8756-8761	which	_	
54-15	8762-8770	resulted	_	
54-16	8771-8773	in	_	
54-17	8774-8776	52	_	
54-18	8777-8785	channels	_	
54-19	8786-8791	total	_	
54-20	8791-8792	.	_	

#Text=Specifically, the detector between Channel 5 and 6 was located at Fz, Channel 46 and 49 were placed in Fp2 and Fp1, and the emitters which were close to Channel 43 and 52 were fitted around T4 and T3, respectively.
55-1	8793-8805	Specifically	_	
55-2	8805-8806	,	_	
55-3	8807-8810	the	_	
55-4	8811-8819	detector	_	
55-5	8820-8827	between	_	
55-6	8828-8835	Channel	_	
55-7	8836-8837	5	_	
55-8	8838-8841	and	_	
55-9	8842-8843	6	_	
55-10	8844-8847	was	_	
55-11	8848-8855	located	_	
55-12	8856-8858	at	_	
55-13	8859-8861	Fz	_	
55-14	8861-8862	,	_	
55-15	8863-8870	Channel	_	
55-16	8871-8873	46	_	
55-17	8874-8877	and	_	
55-18	8878-8880	49	_	
55-19	8881-8885	were	_	
55-20	8886-8892	placed	_	
55-21	8893-8895	in	_	
55-22	8896-8899	Fp2	_	
55-23	8900-8903	and	_	
55-24	8904-8907	Fp1	_	
55-25	8907-8908	,	_	
55-26	8909-8912	and	_	
55-27	8913-8916	the	_	
55-28	8917-8925	emitters	_	
55-29	8926-8931	which	_	
55-30	8932-8936	were	_	
55-31	8937-8942	close	_	
55-32	8943-8945	to	_	
55-33	8946-8953	Channel	_	
55-34	8954-8956	43	_	
55-35	8957-8960	and	_	
55-36	8961-8963	52	_	
55-37	8964-8968	were	_	
55-38	8969-8975	fitted	_	
55-39	8976-8982	around	_	
55-40	8983-8985	T4	_	
55-41	8986-8989	and	_	
55-42	8990-8992	T3	_	
55-43	8992-8993	,	_	
55-44	8994-9006	respectively	_	
55-45	9006-9007	.	_	

#Text=Fz, Fp2, Fp1, T4 and T3 are the reference electrode positions in the international 10-20 system, shown in Fig. 1.
56-1	9008-9010	Fz	_	
56-2	9010-9011	,	_	
56-3	9012-9015	Fp2	_	
56-4	9015-9016	,	_	
56-5	9017-9020	Fp1	_	
56-6	9020-9021	,	_	
56-7	9022-9024	T4	_	
56-8	9025-9028	and	_	
56-9	9029-9031	T3	_	
56-10	9032-9035	are	_	
56-11	9036-9039	the	_	
56-12	9040-9049	reference	_	
56-13	9050-9059	electrode	_	
56-14	9060-9069	positions	_	
56-15	9070-9072	in	_	
56-16	9073-9076	the	_	
56-17	9077-9090	international	_	
56-18	9091-9093	10	_	
56-19	9093-9094	-	_	
56-20	9094-9096	20	_	
56-21	9097-9103	system	_	
56-22	9103-9104	,	_	
56-23	9105-9110	shown	_	
56-24	9111-9113	in	_	
56-25	9114-9117	Fig	_	
56-26	9117-9118	.	_	
56-27	9118-9119	 	_	
56-28	9119-9120	1	_	
56-29	9120-9121	.	_	

#Text=Thus, the fNIRS probe set covered the entire prefrontal cortex and some regions of the superior temporal cortex.
57-1	9122-9126	Thus	_	
57-2	9126-9127	,	_	
57-3	9128-9131	the	_	
57-4	9132-9137	fNIRS	_	
57-5	9138-9143	probe	_	
57-6	9144-9147	set	_	
57-7	9148-9155	covered	_	
57-8	9156-9159	the	_	
57-9	9160-9166	entire	_	
57-10	9167-9177	prefrontal	_	
57-11	9178-9184	cortex	_	
57-12	9185-9188	and	_	
57-13	9189-9193	some	_	
57-14	9194-9201	regions	_	
57-15	9202-9204	of	_	
57-16	9205-9208	the	_	
57-17	9209-9217	superior	_	
57-18	9218-9226	temporal	_	
57-19	9227-9233	cortex	_	
57-20	9233-9234	.	_	

#Text=The relative changes in oxy-Hb and deoxy-Hb were measured using a reflectance mode with two different wavelengths (695 and 830 nm) of near-infrared light.
58-1	9235-9238	The	_	
58-2	9239-9247	relative	_	
58-3	9248-9255	changes	_	
58-4	9256-9258	in	_	
58-5	9259-9265	oxy-Hb	_	
58-6	9266-9269	and	_	
58-7	9270-9278	deoxy-Hb	_	
58-8	9279-9283	were	_	
58-9	9284-9292	measured	_	
58-10	9293-9298	using	_	
58-11	9299-9300	a	_	
58-12	9301-9312	reflectance	_	
58-13	9313-9317	mode	_	
58-14	9318-9322	with	_	
58-15	9323-9326	two	_	
58-16	9327-9336	different	_	
58-17	9337-9348	wavelengths	_	
58-18	9349-9350	(	_	
58-19	9350-9353	695	_	
58-20	9354-9357	and	_	
58-21	9358-9361	830	_	
58-22	9362-9364	nm	_	
58-23	9364-9365	)	_	
58-24	9366-9368	of	_	
58-25	9369-9382	near-infrared	_	
58-26	9383-9388	light	_	
58-27	9388-9389	.	_	

#Text=The relative changes in total-Hb were equal to the sum of oxy-Hb and deoxy-Hb.
59-1	9390-9393	The	_	
59-2	9394-9402	relative	_	
59-3	9403-9410	changes	_	
59-4	9411-9413	in	_	
59-5	9414-9422	total-Hb	_	
59-6	9423-9427	were	_	
59-7	9428-9433	equal	_	
59-8	9434-9436	to	_	
59-9	9437-9440	the	_	
59-10	9441-9444	sum	_	
59-11	9445-9447	of	_	
59-12	9448-9454	oxy-Hb	_	
59-13	9455-9458	and	_	
59-14	9459-9467	deoxy-Hb	_	
59-15	9467-9468	.	_	

#Text=The temporal resolution of fNIRS was set to 0.1 s.
60-1	9469-9472	The	_	
60-2	9473-9481	temporal	_	
60-3	9482-9492	resolution	_	
60-4	9493-9495	of	_	
60-5	9496-9501	fNIRS	_	
60-6	9502-9505	was	_	
60-7	9506-9509	set	_	
60-8	9510-9512	to	_	
60-9	9513-9516	0.1	_	
60-10	9517-9518	s	_	
60-11	9518-9519	.	_	

#Text=The dataset included 42 patients with schizophrenia (mean age: 31 ± 12 years, female/male: 26/16) and 34 ageand sex-matched healthy controls (mean age: 33 ± 10 years, female/male: 20/14).
61-1	9522-9525	The	_	
61-2	9526-9533	dataset	_	
61-3	9534-9542	included	_	
61-4	9543-9545	42	_	
61-5	9546-9554	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
61-6	9555-9559	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
61-7	9560-9573	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
61-8	9574-9575	(	_	
61-9	9575-9579	mean	_	
61-10	9580-9583	age	_	
61-11	9583-9584	:	_	
61-12	9585-9587	31	_	
61-13	9588-9589	±	_	
61-14	9590-9592	12	_	
61-15	9593-9598	years	_	
61-16	9598-9599	,	_	
61-17	9600-9606	female	_	
61-18	9606-9607	/	_	
61-19	9607-9611	male	_	
61-20	9611-9612	:	_	
61-21	9613-9615	26	_	
61-22	9615-9616	/	_	
61-23	9616-9618	16	_	
61-24	9618-9619	)	_	
61-25	9620-9623	and	_	
61-26	9624-9626	34	_	
61-27	9627-9633	ageand	_	
61-28	9634-9645	sex-matched	_	
61-29	9646-9653	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
61-30	9654-9662	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
61-31	9663-9664	(	_	
61-32	9664-9668	mean	_	
61-33	9669-9672	age	_	
61-34	9672-9673	:	_	
61-35	9674-9676	33	_	
61-36	9677-9678	±	_	
61-37	9679-9681	10	_	
61-38	9682-9687	years	_	
61-39	9687-9688	,	_	
61-40	9689-9695	female	_	
61-41	9695-9696	/	_	
61-42	9696-9700	male	_	
61-43	9700-9701	:	_	
61-44	9702-9704	20	_	
61-45	9704-9705	/	_	
61-46	9705-9707	14	_	
61-47	9707-9708	)	_	
61-48	9708-9709	.	_	

#Text=All subjects were right-handed and native Chinese speakers.
62-1	9710-9713	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
62-2	9714-9722	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
62-3	9723-9727	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
62-4	9728-9740	right-handed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
62-5	9741-9744	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
62-6	9745-9751	native	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
62-7	9752-9759	Chinese	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
62-8	9760-9768	speakers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
62-9	9768-9769	.	_	

#Text=The diagnosis for schizophrenia was based on the Structured Clinical Interview for the DSM-IV (American Psychiatric Association, 1994).
63-1	9770-9773	The	_	
63-2	9774-9783	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[9]	
63-3	9784-9787	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[9]	
63-4	9788-9801	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[9]	
63-5	9802-9805	was	_	
63-6	9806-9811	based	_	
63-7	9812-9814	on	_	
63-8	9815-9818	the	_	
63-9	9819-9829	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
63-10	9830-9838	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
63-11	9839-9848	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
63-12	9849-9852	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
63-13	9853-9856	the	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
63-14	9857-9863	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[10]	
63-15	9864-9865	(	_	
63-16	9865-9873	American	_	
63-17	9874-9885	Psychiatric	_	
63-18	9886-9897	Association	_	
63-19	9897-9898	,	_	
63-20	9899-9903	1994	_	
63-21	9903-9904	)	_	
63-22	9904-9905	.	_	

#Text=The healthy controls were enrolled through the local community and then assessed to confirm no history of psychiatric or neurologic disorders.
64-1	9906-9909	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-2	9910-9917	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
64-3	9918-9926	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
64-4	9927-9931	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-5	9932-9940	enrolled	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-6	9941-9948	through	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-7	9949-9952	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-8	9953-9958	local	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-9	9959-9968	community	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-10	9969-9972	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-11	9973-9977	then	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-12	9978-9986	assessed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-13	9987-9989	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-14	9990-9997	confirm	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-15	9998-10000	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-16	10001-10008	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-17	10009-10011	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-18	10012-10023	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-19	10024-10026	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-20	10027-10037	neurologic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-21	10038-10047	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
64-22	10047-10048	.	_	

#Text=This study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee of Peking University Sixth Hospital.
65-1	10049-10053	This	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-2	10054-10059	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-3	10060-10063	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-4	10064-10073	conducted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-5	10074-10076	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-6	10077-10087	accordance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-7	10088-10092	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-8	10093-10096	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-9	10097-10108	Declaration	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-10	10109-10111	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-11	10112-10120	Helsinki	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-12	10121-10124	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-13	10125-10128	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-14	10129-10137	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-15	10138-10140	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-16	10141-10144	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-17	10145-10151	ethics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-18	10152-10161	committee	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-19	10162-10164	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-20	10165-10171	Peking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-21	10172-10182	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-22	10183-10188	Sixth	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-23	10189-10197	Hospital	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
65-24	10197-10198	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	

#Text=All subjects provided written informed consent after the experimental procedure had been fully explained.
66-1	10199-10202	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-2	10203-10211	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-3	10212-10220	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-4	10221-10228	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-5	10229-10237	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-6	10238-10245	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-7	10246-10251	after	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-8	10252-10255	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-9	10256-10268	experimental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-10	10269-10278	procedure	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-11	10279-10282	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-12	10283-10287	been	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-13	10288-10293	fully	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-14	10294-10303	explained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
66-15	10303-10304	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=The time variance in the data retrieval
#Text=The experiment was performed in a quiet environment.
67-1	10305-10308	The	_	
67-2	10309-10313	time	_	
67-3	10314-10322	variance	_	
67-4	10323-10325	in	_	
67-5	10326-10329	the	_	
67-6	10330-10334	data	_	
67-7	10335-10344	retrieval	_	
67-8	10345-10348	The	_	
67-9	10349-10359	experiment	_	
67-10	10360-10363	was	_	
67-11	10364-10373	performed	_	
67-12	10374-10376	in	_	
67-13	10377-10378	a	_	
67-14	10379-10384	quiet	_	
67-15	10385-10396	environment	_	
67-16	10396-10397	.	_	

#Text=All subjects were required to maintain emotionally stability prior to the experiment and to avoid moving the head as much as possible during the measurement.
68-1	10398-10401	All	_	
68-2	10402-10410	subjects	_	
68-3	10411-10415	were	_	
68-4	10416-10424	required	_	
68-5	10425-10427	to	_	
68-6	10428-10436	maintain	_	
68-7	10437-10448	emotionally	_	
68-8	10449-10458	stability	_	
68-9	10459-10464	prior	_	
68-10	10465-10467	to	_	
68-11	10468-10471	the	_	
68-12	10472-10482	experiment	_	
68-13	10483-10486	and	_	
68-14	10487-10489	to	_	
68-15	10490-10495	avoid	_	
68-16	10496-10502	moving	_	
68-17	10503-10506	the	_	
68-18	10507-10511	head	_	
68-19	10512-10514	as	_	
68-20	10515-10519	much	_	
68-21	10520-10522	as	_	
68-22	10523-10531	possible	_	
68-23	10532-10538	during	_	
68-24	10539-10542	the	_	
68-25	10543-10554	measurement	_	
68-26	10554-10555	.	_	

#Text=We designed a one-back memory task.
69-1	10556-10558	We	_	
69-2	10559-10567	designed	_	
69-3	10568-10569	a	_	
69-4	10570-10578	one-back	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[15]	
69-5	10579-10585	memory	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[15]	
69-6	10586-10590	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[15]	
69-7	10590-10591	.	_	

#Text=The task comprised a 5s pre-scan and a 25s waiting period, a 70s task period, and a 50s post-task baseline period.
70-1	10592-10595	The	_	
70-2	10596-10600	task	_	
70-3	10601-10610	comprised	_	
70-4	10611-10612	a	_	
70-5	10613-10615	5s	_	
70-6	10616-10624	pre-scan	_	
70-7	10625-10628	and	_	
70-8	10629-10630	a	_	
70-9	10631-10634	25s	_	
70-10	10635-10642	waiting	_	
70-11	10643-10649	period	_	
70-12	10649-10650	,	_	
70-13	10651-10652	a	_	
70-14	10653-10656	70s	_	
70-15	10657-10661	task	_	
70-16	10662-10668	period	_	
70-17	10668-10669	,	_	
70-18	10670-10673	and	_	
70-19	10674-10675	a	_	
70-20	10676-10679	50s	_	
70-21	10680-10689	post-task	_	
70-22	10690-10698	baseline	_	
70-23	10699-10705	period	_	
70-24	10705-10706	.	_	

#Text=We can see it in Fig. 2.
71-1	10707-10709	We	_	
71-2	10710-10713	can	_	
71-3	10714-10717	see	_	
71-4	10718-10720	it	_	
71-5	10721-10723	in	_	
71-6	10724-10727	Fig	_	
71-7	10727-10728	.	_	
71-8	10728-10729	 	_	
71-9	10729-10730	2	_	
71-10	10730-10731	.	_	

#Text=During the pre- and post-task baseline periods, the subjects were required to stare the screen.
72-1	10732-10738	During	_	
72-2	10739-10742	the	_	
72-3	10743-10746	pre	_	
72-4	10746-10747	-	_	
72-5	10748-10751	and	_	
72-6	10752-10761	post-task	_	
72-7	10762-10770	baseline	_	
72-8	10771-10778	periods	_	
72-9	10778-10779	,	_	
72-10	10780-10783	the	_	
72-11	10784-10792	subjects	_	
72-12	10793-10797	were	_	
72-13	10798-10806	required	_	
72-14	10807-10809	to	_	
72-15	10810-10815	stare	_	
72-16	10816-10819	the	_	
72-17	10820-10826	screen	_	
72-18	10826-10827	.	_	

#Text=During the task period, they were instructed to press a button with their right index finger whether or not the current image presented on the screen was the same as the previously shown one.
73-1	10828-10834	During	_	
73-2	10835-10838	the	_	
73-3	10839-10843	task	_	
73-4	10844-10850	period	_	
73-5	10850-10851	,	_	
73-6	10852-10856	they	_	
73-7	10857-10861	were	_	
73-8	10862-10872	instructed	_	
73-9	10873-10875	to	_	
73-10	10876-10881	press	_	
73-11	10882-10883	a	_	
73-12	10884-10890	button	_	
73-13	10891-10895	with	_	
73-14	10896-10901	their	_	
73-15	10902-10907	right	_	
73-16	10908-10913	index	_	
73-17	10914-10920	finger	_	
73-18	10921-10928	whether	_	
73-19	10929-10931	or	_	
73-20	10932-10935	not	_	
73-21	10936-10939	the	_	
73-22	10940-10947	current	_	
73-23	10948-10953	image	_	
73-24	10954-10963	presented	_	
73-25	10964-10966	on	_	
73-26	10967-10970	the	_	
73-27	10971-10977	screen	_	
73-28	10978-10981	was	_	
73-29	10982-10985	the	_	
73-30	10986-10990	same	_	
73-31	10991-10993	as	_	
73-32	10994-10997	the	_	
73-33	10998-11008	previously	_	
73-34	11009-11014	shown	_	
73-35	11015-11018	one	_	
73-36	11018-11019	.	_	

#Text=The images were changed every 2s and the rendering time was 0.5s, there were a total of 29 figures shown.
74-1	11020-11023	The	_	
74-2	11024-11030	images	_	
74-3	11031-11035	were	_	
74-4	11036-11043	changed	_	
74-5	11044-11049	every	_	
74-6	11050-11052	2s	_	
74-7	11053-11056	and	_	
74-8	11057-11060	the	_	
74-9	11061-11070	rendering	_	
74-10	11071-11075	time	_	
74-11	11076-11079	was	_	
74-12	11080-11084	0.5s	_	
74-13	11084-11085	,	_	
74-14	11086-11091	there	_	
74-15	11092-11096	were	_	
74-16	11097-11098	a	_	
74-17	11099-11104	total	_	
74-18	11105-11107	of	_	
74-19	11108-11110	29	_	
74-20	11111-11118	figures	_	
74-21	11119-11124	shown	_	
74-22	11124-11125	.	_	

#Text=A detailed description of this experimental procedure could be found in elsewhere.
75-1	11126-11127	A	_	
75-2	11128-11136	detailed	_	
75-3	11137-11148	description	_	
75-4	11149-11151	of	_	
75-5	11152-11156	this	_	
75-6	11157-11169	experimental	_	
75-7	11170-11179	procedure	_	
75-8	11180-11185	could	_	
75-9	11186-11188	be	_	
75-10	11189-11194	found	_	
75-11	11195-11197	in	_	
75-12	11198-11207	elsewhere	_	
75-13	11207-11208	.	_	

#Text=Schizophrenic discrimination method
#Text=The framework of schizophrenia discrimination
#Text=The process of schizophrenia discrimination includes preprocessing the fNIRS data, constructing brain network, feature extraction, training the classifier, cross validation and testing.
76-1	11211-11224	Schizophrenic	_	
76-2	11225-11239	discrimination	_	
76-3	11240-11246	method	_	
76-4	11247-11250	The	_	
76-5	11251-11260	framework	_	
76-6	11261-11263	of	_	
76-7	11264-11277	schizophrenia	_	
76-8	11278-11292	discrimination	_	
76-9	11293-11296	The	_	
76-10	11297-11304	process	_	
76-11	11305-11307	of	_	
76-12	11308-11321	schizophrenia	_	
76-13	11322-11336	discrimination	_	
76-14	11337-11345	includes	_	
76-15	11346-11359	preprocessing	_	
76-16	11360-11363	the	_	
76-17	11364-11369	fNIRS	_	
76-18	11370-11374	data	_	
76-19	11374-11375	,	_	
76-20	11376-11388	constructing	_	
76-21	11389-11394	brain	_	
76-22	11395-11402	network	_	
76-23	11402-11403	,	_	
76-24	11404-11411	feature	_	
76-25	11412-11422	extraction	_	
76-26	11422-11423	,	_	
76-27	11424-11432	training	_	
76-28	11433-11436	the	_	
76-29	11437-11447	classifier	_	
76-30	11447-11448	,	_	
76-31	11449-11454	cross	_	
76-32	11455-11465	validation	_	
76-33	11466-11469	and	_	
76-34	11470-11477	testing	_	
76-35	11477-11478	.	_	

#Text=The flowchart of schizophrenia discrimination process is shown in Fig. 3.
77-1	11479-11482	The	_	
77-2	11483-11492	flowchart	_	
77-3	11493-11495	of	_	
77-4	11496-11509	schizophrenia	_	
77-5	11510-11524	discrimination	_	
77-6	11525-11532	process	_	
77-7	11533-11535	is	_	
77-8	11536-11541	shown	_	
77-9	11542-11544	in	_	
77-10	11545-11548	Fig	_	
77-11	11548-11549	.	_	
77-12	11549-11550	 	_	
77-13	11550-11551	3	_	
77-14	11551-11552	.	_	

#Text=In this paper, CBNA is used to extract the feature eigenvalues and SVM is used as the classifier.
78-1	11553-11555	In	_	
78-2	11556-11560	this	_	
78-3	11561-11566	paper	_	
78-4	11566-11567	,	_	
78-5	11568-11572	CBNA	_	
78-6	11573-11575	is	_	
78-7	11576-11580	used	_	
78-8	11581-11583	to	_	
78-9	11584-11591	extract	_	
78-10	11592-11595	the	_	
78-11	11596-11603	feature	_	
78-12	11604-11615	eigenvalues	_	
78-13	11616-11619	and	_	
78-14	11620-11623	SVM	_	
78-15	11624-11626	is	_	
78-16	11627-11631	used	_	
78-17	11632-11634	as	_	
78-18	11635-11638	the	_	
78-19	11639-11649	classifier	_	
78-20	11649-11650	.	_	

#Text=Preprocessing data
#Text=Original oxy hemoglobin concentration
#Text=The fourier transform of original oxy hemoglobin concentration of normal and schizophrenia people
#Text=Oxy hemoglobin concentration before and after low-pass filtering
#Text=The original fNIRS data of a schizophrenia patient is shown in Fig. 4, the blue line plots the oxy hemoglobin concentration variation of healthy person.
79-1	11653-11666	Preprocessing	_	
79-2	11667-11671	data	_	
79-3	11672-11680	Original	_	
79-4	11681-11684	oxy	_	
79-5	11685-11695	hemoglobin	_	
79-6	11696-11709	concentration	_	
79-7	11710-11713	The	_	
79-8	11714-11721	fourier	_	
79-9	11722-11731	transform	_	
79-10	11732-11734	of	_	
79-11	11735-11743	original	_	
79-12	11744-11747	oxy	_	
79-13	11748-11758	hemoglobin	_	
79-14	11759-11772	concentration	_	
79-15	11773-11775	of	_	
79-16	11776-11782	normal	_	
79-17	11783-11786	and	_	
79-18	11787-11800	schizophrenia	_	
79-19	11801-11807	people	_	
79-20	11808-11811	Oxy	_	
79-21	11812-11822	hemoglobin	_	
79-22	11823-11836	concentration	_	
79-23	11837-11843	before	_	
79-24	11844-11847	and	_	
79-25	11848-11853	after	_	
79-26	11854-11862	low-pass	_	
79-27	11863-11872	filtering	_	
79-28	11873-11876	The	_	
79-29	11877-11885	original	_	
79-30	11886-11891	fNIRS	_	
79-31	11892-11896	data	_	
79-32	11897-11899	of	_	
79-33	11900-11901	a	_	
79-34	11902-11915	schizophrenia	_	
79-35	11916-11923	patient	_	
79-36	11924-11926	is	_	
79-37	11927-11932	shown	_	
79-38	11933-11935	in	_	
79-39	11936-11939	Fig	_	
79-40	11939-11940	.	_	
79-41	11940-11941	 	_	
79-42	11941-11942	4	_	
79-43	11942-11943	,	_	
79-44	11944-11947	the	_	
79-45	11948-11952	blue	_	
79-46	11953-11957	line	_	
79-47	11958-11963	plots	_	
79-48	11964-11967	the	_	
79-49	11968-11971	oxy	_	
79-50	11972-11982	hemoglobin	_	
79-51	11983-11996	concentration	_	
79-52	11997-12006	variation	_	
79-53	12007-12009	of	_	
79-54	12010-12017	healthy	_	
79-55	12018-12024	person	_	
79-56	12024-12025	.	_	

#Text=In order to reduce the effects of the high frequency noise, low-pass filtering is used to do data preprocessing.
80-1	12026-12028	In	_	
80-2	12029-12034	order	_	
80-3	12035-12037	to	_	
80-4	12038-12044	reduce	_	
80-5	12045-12048	the	_	
80-6	12049-12056	effects	_	
80-7	12057-12059	of	_	
80-8	12060-12063	the	_	
80-9	12064-12068	high	_	
80-10	12069-12078	frequency	_	
80-11	12079-12084	noise	_	
80-12	12084-12085	,	_	
80-13	12086-12094	low-pass	_	
80-14	12095-12104	filtering	_	
80-15	12105-12107	is	_	
80-16	12108-12112	used	_	
80-17	12113-12115	to	_	
80-18	12116-12118	do	_	
80-19	12119-12123	data	_	
80-20	12124-12137	preprocessing	_	
80-21	12137-12138	.	_	

#Text=Before low-pass filtering, We first use Fast Fourier transform to do spectrum analysis to find which frequency the fNIRS exists in.
81-1	12139-12145	Before	_	
81-2	12146-12154	low-pass	_	
81-3	12155-12164	filtering	_	
81-4	12164-12165	,	_	
81-5	12166-12168	We	_	
81-6	12169-12174	first	_	
81-7	12175-12178	use	_	
81-8	12179-12183	Fast	_	
81-9	12184-12191	Fourier	_	
81-10	12192-12201	transform	_	
81-11	12202-12204	to	_	
81-12	12205-12207	do	_	
81-13	12208-12216	spectrum	_	
81-14	12217-12225	analysis	_	
81-15	12226-12228	to	_	
81-16	12229-12233	find	_	
81-17	12234-12239	which	_	
81-18	12240-12249	frequency	_	
81-19	12250-12253	the	_	
81-20	12254-12259	fNIRS	_	
81-21	12260-12266	exists	_	
81-22	12267-12269	in	_	
81-23	12269-12270	.	_	

#Text=Figure 5 shows the Fast Fourier transform result of original oxy hemoglobin concentration variation of healthy person and schizophrenia patient, blue line represents the healthy person and red line represents the schizophrenia patient.
82-1	12271-12277	Figure	_	
82-2	12277-12278	 	_	
82-3	12278-12279	5	_	
82-4	12280-12285	shows	_	
82-5	12286-12289	the	_	
82-6	12290-12294	Fast	_	
82-7	12295-12302	Fourier	_	
82-8	12303-12312	transform	_	
82-9	12313-12319	result	_	
82-10	12320-12322	of	_	
82-11	12323-12331	original	_	
82-12	12332-12335	oxy	_	
82-13	12336-12346	hemoglobin	_	
82-14	12347-12360	concentration	_	
82-15	12361-12370	variation	_	
82-16	12371-12373	of	_	
82-17	12374-12381	healthy	_	
82-18	12382-12388	person	_	
82-19	12389-12392	and	_	
82-20	12393-12406	schizophrenia	_	
82-21	12407-12414	patient	_	
82-22	12414-12415	,	_	
82-23	12416-12420	blue	_	
82-24	12421-12425	line	_	
82-25	12426-12436	represents	_	
82-26	12437-12440	the	_	
82-27	12441-12448	healthy	_	
82-28	12449-12455	person	_	
82-29	12456-12459	and	_	
82-30	12460-12463	red	_	
82-31	12464-12468	line	_	
82-32	12469-12479	represents	_	
82-33	12480-12483	the	_	
82-34	12484-12497	schizophrenia	_	
82-35	12498-12505	patient	_	
82-36	12505-12506	.	_	

#Text=It is obviously that the frequency of fNIRS signal mainly exists in 0.0–0.5 HZ, so a low-pass filter with the cut-off frequency 0.5 Hz is designed to do the filtering.
83-1	12507-12509	It	_	
83-2	12510-12512	is	_	
83-3	12513-12522	obviously	_	
83-4	12523-12527	that	_	
83-5	12528-12531	the	_	
83-6	12532-12541	frequency	_	
83-7	12542-12544	of	_	
83-8	12545-12550	fNIRS	_	
83-9	12551-12557	signal	_	
83-10	12558-12564	mainly	_	
83-11	12565-12571	exists	_	
83-12	12572-12574	in	_	
83-13	12575-12578	0.0	_	
83-14	12578-12579	–	_	
83-15	12579-12582	0.5	_	
83-16	12583-12585	HZ	_	
83-17	12585-12586	,	_	
83-18	12587-12589	so	_	
83-19	12590-12591	a	_	
83-20	12592-12600	low-pass	_	
83-21	12601-12607	filter	_	
83-22	12608-12612	with	_	
83-23	12613-12616	the	_	
83-24	12617-12624	cut-off	_	
83-25	12625-12634	frequency	_	
83-26	12635-12638	0.5	_	
83-27	12639-12641	Hz	_	
83-28	12642-12644	is	_	
83-29	12645-12653	designed	_	
83-30	12654-12656	to	_	
83-31	12657-12659	do	_	
83-32	12660-12663	the	_	
83-33	12664-12673	filtering	_	
83-34	12673-12674	.	_	

#Text=The result of the low-pass filtering is shown in Fig. 6.
84-1	12675-12678	The	_	
84-2	12679-12685	result	_	
84-3	12686-12688	of	_	
84-4	12689-12692	the	_	
84-5	12693-12701	low-pass	_	
84-6	12702-12711	filtering	_	
84-7	12712-12714	is	_	
84-8	12715-12720	shown	_	
84-9	12721-12723	in	_	
84-10	12724-12727	Fig	_	
84-11	12727-12728	.	_	
84-12	12728-12729	 	_	
84-13	12729-12730	6	_	
84-14	12730-12731	.	_	

#Text=The blue line represents original data and red line represents processed data.
85-1	12732-12735	The	_	
85-2	12736-12740	blue	_	
85-3	12741-12745	line	_	
85-4	12746-12756	represents	_	
85-5	12757-12765	original	_	
85-6	12766-12770	data	_	
85-7	12771-12774	and	_	
85-8	12775-12778	red	_	
85-9	12779-12783	line	_	
85-10	12784-12794	represents	_	
85-11	12795-12804	processed	_	
85-12	12805-12809	data	_	
85-13	12809-12810	.	_	

#Text=It can be seen that the curve after low-pass filter is smoother than before, some high frequency noise is reduced.
86-1	12811-12813	It	_	
86-2	12814-12817	can	_	
86-3	12818-12820	be	_	
86-4	12821-12825	seen	_	
86-5	12826-12830	that	_	
86-6	12831-12834	the	_	
86-7	12835-12840	curve	_	
86-8	12841-12846	after	_	
86-9	12847-12855	low-pass	_	
86-10	12856-12862	filter	_	
86-11	12863-12865	is	_	
86-12	12866-12874	smoother	_	
86-13	12875-12879	than	_	
86-14	12880-12886	before	_	
86-15	12886-12887	,	_	
86-16	12888-12892	some	_	
86-17	12893-12897	high	_	
86-18	12898-12907	frequency	_	
86-19	12908-12913	noise	_	
86-20	12914-12916	is	_	
86-21	12917-12924	reduced	_	
86-22	12924-12925	.	_	

#Text=This reduced the effects of high frequency noise and improved the classification accuracy.
87-1	12926-12930	This	_	
87-2	12931-12938	reduced	_	
87-3	12939-12942	the	_	
87-4	12943-12950	effects	_	
87-5	12951-12953	of	_	
87-6	12954-12958	high	_	
87-7	12959-12968	frequency	_	
87-8	12969-12974	noise	_	
87-9	12975-12978	and	_	
87-10	12979-12987	improved	_	
87-11	12988-12991	the	_	
87-12	12992-13006	classification	_	
87-13	13007-13015	accuracy	_	
87-14	13015-13016	.	_	

#Text=Construct the brain network
#Text=The flow chart of functional brain network construction
#Text=The process of a functional brain network construction is shown in Fig. 7.
88-1	13021-13030	Construct	_	
88-2	13031-13034	the	_	
88-3	13035-13040	brain	_	
88-4	13041-13048	network	_	
88-5	13049-13052	The	_	
88-6	13053-13057	flow	_	
88-7	13058-13063	chart	_	
88-8	13064-13066	of	_	
88-9	13067-13077	functional	_	
88-10	13078-13083	brain	_	
88-11	13084-13091	network	_	
88-12	13092-13104	construction	_	
88-13	13105-13108	The	_	
88-14	13109-13116	process	_	
88-15	13117-13119	of	_	
88-16	13120-13121	a	_	
88-17	13122-13132	functional	_	
88-18	13133-13138	brain	_	
88-19	13139-13146	network	_	
88-20	13147-13159	construction	_	
88-21	13160-13162	is	_	
88-22	13163-13168	shown	_	
88-23	13169-13171	in	_	
88-24	13172-13175	Fig	_	
88-25	13175-13176	.	_	
88-26	13176-13177	 	_	
88-27	13177-13178	7	_	
88-28	13178-13179	.	_	

#Text=During the construction process, defining the edge and node of the brain network are two important steps.
89-1	13180-13186	During	_	
89-2	13187-13190	the	_	
89-3	13191-13203	construction	_	
89-4	13204-13211	process	_	
89-5	13211-13212	,	_	
89-6	13213-13221	defining	_	
89-7	13222-13225	the	_	
89-8	13226-13230	edge	_	
89-9	13231-13234	and	_	
89-10	13235-13239	node	_	
89-11	13240-13242	of	_	
89-12	13243-13246	the	_	
89-13	13247-13252	brain	_	
89-14	13253-13260	network	_	
89-15	13261-13264	are	_	
89-16	13265-13268	two	_	
89-17	13269-13278	important	_	
89-18	13279-13284	steps	_	
89-19	13284-13285	.	_	

#Text=Nodes in the brain network correspond to the measured 52 channels of fNIRS.
90-1	13286-13291	Nodes	_	
90-2	13292-13294	in	_	
90-3	13295-13298	the	_	
90-4	13299-13304	brain	_	
90-5	13305-13312	network	_	
90-6	13313-13323	correspond	_	
90-7	13324-13326	to	_	
90-8	13327-13330	the	_	
90-9	13331-13339	measured	_	
90-10	13340-13342	52	_	
90-11	13343-13351	channels	_	
90-12	13352-13354	of	_	
90-13	13355-13360	fNIRS	_	
90-14	13360-13361	.	_	

#Text=The Pearson correlation coefficient of fNIRS time series between different nodes is usually calculated to quantify the relationship between them.
91-1	13362-13365	The	_	
91-2	13366-13373	Pearson	_	
91-3	13374-13385	correlation	_	
91-4	13386-13397	coefficient	_	
91-5	13398-13400	of	_	
91-6	13401-13406	fNIRS	_	
91-7	13407-13411	time	_	
91-8	13412-13418	series	_	
91-9	13419-13426	between	_	
91-10	13427-13436	different	_	
91-11	13437-13442	nodes	_	
91-12	13443-13445	is	_	
91-13	13446-13453	usually	_	
91-14	13454-13464	calculated	_	
91-15	13465-13467	to	_	
91-16	13468-13476	quantify	_	
91-17	13477-13480	the	_	
91-18	13481-13493	relationship	_	
91-19	13494-13501	between	_	
91-20	13502-13506	them	_	
91-21	13506-13507	.	_	

#Text=The edge is defined by setting an appropriate threshold to binarize the connection relationship of the nodes.
92-1	13508-13511	The	_	
92-2	13512-13516	edge	_	
92-3	13517-13519	is	_	
92-4	13520-13527	defined	_	
92-5	13528-13530	by	_	
92-6	13531-13538	setting	_	
92-7	13539-13541	an	_	
92-8	13542-13553	appropriate	_	
92-9	13554-13563	threshold	_	
92-10	13564-13566	to	_	
92-11	13567-13575	binarize	_	
92-12	13576-13579	the	_	
92-13	13580-13590	connection	_	
92-14	13591-13603	relationship	_	
92-15	13604-13606	of	_	
92-16	13607-13610	the	_	
92-17	13611-13616	nodes	_	
92-18	13616-13617	.	_	

#Text=The Pearson correlation coefficient is calculated as follows, take the i th and j th channel’s fNRIS data as variable X,Y(i,j=1,2…52,i≠j), the Pearson correlation coefficient is r i,j, then   
#Text=Where c o v(X,Y) is the covariance, σ X, σ Y are the standard deviation, μ X, μ Y are the mean of variable X and Y respectively.
93-1	13620-13623	The	_	
93-2	13624-13631	Pearson	_	
93-3	13632-13643	correlation	_	
93-4	13644-13655	coefficient	_	
93-5	13656-13658	is	_	
93-6	13659-13669	calculated	_	
93-7	13670-13672	as	_	
93-8	13673-13680	follows	_	
93-9	13680-13681	,	_	
93-10	13682-13686	take	_	
93-11	13687-13690	the	_	
93-12	13691-13692	i	_	
93-13	13693-13695	th	_	
93-14	13696-13699	and	_	
93-15	13700-13701	j	_	
93-16	13702-13704	th	_	
93-17	13705-13712	channel	_	
93-18	13712-13713	’	_	
93-19	13713-13714	s	_	
93-20	13715-13720	fNRIS	_	
93-21	13721-13725	data	_	
93-22	13726-13728	as	_	
93-23	13729-13737	variable	_	
93-24	13738-13739	X	_	
93-25	13739-13740	,	_	
93-26	13740-13741	Y	_	
93-27	13741-13742	(	_	
93-28	13742-13743	i	_	
93-29	13743-13744	,	_	
93-30	13744-13745	j	_	
93-31	13745-13746	=	_	
93-32	13746-13749	1,2	_	
93-33	13749-13750	…	_	
93-34	13750-13752	52	_	
93-35	13752-13753	,	_	
93-36	13753-13754	i	_	
93-37	13754-13755	≠	_	
93-38	13755-13756	j	_	
93-39	13756-13757	)	_	
93-40	13757-13758	,	_	
93-41	13759-13762	the	_	
93-42	13763-13770	Pearson	_	
93-43	13771-13782	correlation	_	
93-44	13783-13794	coefficient	_	
93-45	13795-13797	is	_	
93-46	13798-13799	r	_	
93-47	13800-13801	i	_	
93-48	13801-13802	,	_	
93-49	13802-13803	j	_	
93-50	13803-13804	,	_	
93-51	13805-13809	then	_	
93-52	13813-13818	Where	_	
93-53	13819-13820	c	_	
93-54	13821-13822	o	_	
93-55	13823-13824	v	_	
93-56	13824-13825	(	_	
93-57	13825-13826	X	_	
93-58	13826-13827	,	_	
93-59	13827-13828	Y	_	
93-60	13828-13829	)	_	
93-61	13830-13832	is	_	
93-62	13833-13836	the	_	
93-63	13837-13847	covariance	_	
93-64	13847-13848	,	_	
93-65	13849-13850	σ	_	
93-66	13851-13852	X	_	
93-67	13852-13853	,	_	
93-68	13854-13855	σ	_	
93-69	13856-13857	Y	_	
93-70	13858-13861	are	_	
93-71	13862-13865	the	_	
93-72	13866-13874	standard	_	
93-73	13875-13884	deviation	_	
93-74	13884-13885	,	_	
93-75	13886-13887	μ	_	
93-76	13888-13889	X	_	
93-77	13889-13890	,	_	
93-78	13891-13892	μ	_	
93-79	13893-13894	Y	_	
93-80	13895-13898	are	_	
93-81	13899-13902	the	_	
93-82	13903-13907	mean	_	
93-83	13908-13910	of	_	
93-84	13911-13919	variable	_	
93-85	13920-13921	X	_	
93-86	13922-13925	and	_	
93-87	13926-13927	Y	_	
93-88	13928-13940	respectively	_	
93-89	13940-13941	.	_	

#Text=The Pearson correlation coefficient of two variables X and Y is equal to the covariance divided by the product of the standard deviation of the two variables.
94-1	13942-13945	The	_	
94-2	13946-13953	Pearson	_	
94-3	13954-13965	correlation	_	
94-4	13966-13977	coefficient	_	
94-5	13978-13980	of	_	
94-6	13981-13984	two	_	
94-7	13985-13994	variables	_	
94-8	13995-13996	X	_	
94-9	13997-14000	and	_	
94-10	14001-14002	Y	_	
94-11	14003-14005	is	_	
94-12	14006-14011	equal	_	
94-13	14012-14014	to	_	
94-14	14015-14018	the	_	
94-15	14019-14029	covariance	_	
94-16	14030-14037	divided	_	
94-17	14038-14040	by	_	
94-18	14041-14044	the	_	
94-19	14045-14052	product	_	
94-20	14053-14055	of	_	
94-21	14056-14059	the	_	
94-22	14060-14068	standard	_	
94-23	14069-14078	deviation	_	
94-24	14079-14081	of	_	
94-25	14082-14085	the	_	
94-26	14086-14089	two	_	
94-27	14090-14099	variables	_	
94-28	14099-14100	.	_	

#Text=Pearson correlation coefficient matrix of a schizophrenic patient after color rendering
#Text=From the calculation process of Pearson correlation coefficient, we can get a Pearson correlation coefficient matrix with a row and column which have 52 dimensions for a subject.
95-1	14101-14108	Pearson	_	
95-2	14109-14120	correlation	_	
95-3	14121-14132	coefficient	_	
95-4	14133-14139	matrix	_	
95-5	14140-14142	of	_	
95-6	14143-14144	a	_	
95-7	14145-14158	schizophrenic	_	
95-8	14159-14166	patient	_	
95-9	14167-14172	after	_	
95-10	14173-14178	color	_	
95-11	14179-14188	rendering	_	
95-12	14189-14193	From	_	
95-13	14194-14197	the	_	
95-14	14198-14209	calculation	_	
95-15	14210-14217	process	_	
95-16	14218-14220	of	_	
95-17	14221-14228	Pearson	_	
95-18	14229-14240	correlation	_	
95-19	14241-14252	coefficient	_	
95-20	14252-14253	,	_	
95-21	14254-14256	we	_	
95-22	14257-14260	can	_	
95-23	14261-14264	get	_	
95-24	14265-14266	a	_	
95-25	14267-14274	Pearson	_	
95-26	14275-14286	correlation	_	
95-27	14287-14298	coefficient	_	
95-28	14299-14305	matrix	_	
95-29	14306-14310	with	_	
95-30	14311-14312	a	_	
95-31	14313-14316	row	_	
95-32	14317-14320	and	_	
95-33	14321-14327	column	_	
95-34	14328-14333	which	_	
95-35	14334-14338	have	_	
95-36	14339-14341	52	_	
95-37	14342-14352	dimensions	_	
95-38	14353-14356	for	_	
95-39	14357-14358	a	_	
95-40	14359-14366	subject	_	
95-41	14366-14367	.	_	

#Text=Each element in the matrix is a Pearson correlation coefficient value.
96-1	14368-14372	Each	_	
96-2	14373-14380	element	_	
96-3	14381-14383	in	_	
96-4	14384-14387	the	_	
96-5	14388-14394	matrix	_	
96-6	14395-14397	is	_	
96-7	14398-14399	a	_	
96-8	14400-14407	Pearson	_	
96-9	14408-14419	correlation	_	
96-10	14420-14431	coefficient	_	
96-11	14432-14437	value	_	
96-12	14437-14438	.	_	

#Text=When i=j, the Pearson correlation coefficient is 1.
97-1	14439-14443	When	_	
97-2	14444-14445	i	_	
97-3	14445-14446	=	_	
97-4	14446-14447	j	_	
97-5	14447-14448	,	_	
97-6	14449-14452	the	_	
97-7	14453-14460	Pearson	_	
97-8	14461-14472	correlation	_	
97-9	14473-14484	coefficient	_	
97-10	14485-14487	is	_	
97-11	14488-14489	1	_	
97-12	14489-14490	.	_	

#Text=Here we calculated the Pearson correlation coefficient of 76 subjects and constructed 76 correlation coefficient matrices.
98-1	14491-14495	Here	_	
98-2	14496-14498	we	_	
98-3	14499-14509	calculated	_	
98-4	14510-14513	the	_	
98-5	14514-14521	Pearson	_	
98-6	14522-14533	correlation	_	
98-7	14534-14545	coefficient	_	
98-8	14546-14548	of	_	
98-9	14549-14551	76	_	
98-10	14552-14560	subjects	_	
98-11	14561-14564	and	_	
98-12	14565-14576	constructed	_	
98-13	14577-14579	76	_	
98-14	14580-14591	correlation	_	
98-15	14592-14603	coefficient	_	
98-16	14604-14612	matrices	_	
98-17	14612-14613	.	_	

#Text=Fig. 8 shows the result of Pearson correlation coefficient matrix of a schizophrenic patient after color rendering.
99-1	14614-14617	Fig	_	
99-2	14617-14618	.	_	
99-3	14618-14619	 	_	
99-4	14619-14620	8	_	
99-5	14621-14626	shows	_	
99-6	14627-14630	the	_	
99-7	14631-14637	result	_	
99-8	14638-14640	of	_	
99-9	14641-14648	Pearson	_	
99-10	14649-14660	correlation	_	
99-11	14661-14672	coefficient	_	
99-12	14673-14679	matrix	_	
99-13	14680-14682	of	_	
99-14	14683-14684	a	_	
99-15	14685-14698	schizophrenic	_	
99-16	14699-14706	patient	_	
99-17	14707-14712	after	_	
99-18	14713-14718	color	_	
99-19	14719-14728	rendering	_	
99-20	14728-14729	.	_	

#Text=After quantizing the relationship between 52 channels,we got the Pearson correlation coefficient matrix, it is necessary to choose an appropriate threshold T in order to construct the edge of the nodes.
100-1	14732-14737	After	_	
100-2	14738-14748	quantizing	_	
100-3	14749-14752	the	_	
100-4	14753-14765	relationship	_	
100-5	14766-14773	between	_	
100-6	14774-14776	52	_	
100-7	14777-14785	channels	_	
100-8	14785-14786	,	_	
100-9	14786-14788	we	_	
100-10	14789-14792	got	_	
100-11	14793-14796	the	_	
100-12	14797-14804	Pearson	_	
100-13	14805-14816	correlation	_	
100-14	14817-14828	coefficient	_	
100-15	14829-14835	matrix	_	
100-16	14835-14836	,	_	
100-17	14837-14839	it	_	
100-18	14840-14842	is	_	
100-19	14843-14852	necessary	_	
100-20	14853-14855	to	_	
100-21	14856-14862	choose	_	
100-22	14863-14865	an	_	
100-23	14866-14877	appropriate	_	
100-24	14878-14887	threshold	_	
100-25	14888-14889	T	_	
100-26	14890-14892	in	_	
100-27	14893-14898	order	_	
100-28	14899-14901	to	_	
100-29	14902-14911	construct	_	
100-30	14912-14915	the	_	
100-31	14916-14920	edge	_	
100-32	14921-14923	of	_	
100-33	14924-14927	the	_	
100-34	14928-14933	nodes	_	
100-35	14933-14934	.	_	

#Text=Whether there is an edge connection between two nodes is depend on the Pearson correlation between two channels.If the absolute value of the Pearson correlation coefficient is greater than the threshold, there is an edge between the corresponding nodes, and vice versa.
101-1	14935-14942	Whether	_	
101-2	14943-14948	there	_	
101-3	14949-14951	is	_	
101-4	14952-14954	an	_	
101-5	14955-14959	edge	_	
101-6	14960-14970	connection	_	
101-7	14971-14978	between	_	
101-8	14979-14982	two	_	
101-9	14983-14988	nodes	_	
101-10	14989-14991	is	_	
101-11	14992-14998	depend	_	
101-12	14999-15001	on	_	
101-13	15002-15005	the	_	
101-14	15006-15013	Pearson	_	
101-15	15014-15025	correlation	_	
101-16	15026-15033	between	_	
101-17	15034-15037	two	_	
101-18	15038-15049	channels.If	_	
101-19	15050-15053	the	_	
101-20	15054-15062	absolute	_	
101-21	15063-15068	value	_	
101-22	15069-15071	of	_	
101-23	15072-15075	the	_	
101-24	15076-15083	Pearson	_	
101-25	15084-15095	correlation	_	
101-26	15096-15107	coefficient	_	
101-27	15108-15110	is	_	
101-28	15111-15118	greater	_	
101-29	15119-15123	than	_	
101-30	15124-15127	the	_	
101-31	15128-15137	threshold	_	
101-32	15137-15138	,	_	
101-33	15139-15144	there	_	
101-34	15145-15147	is	_	
101-35	15148-15150	an	_	
101-36	15151-15155	edge	_	
101-37	15156-15163	between	_	
101-38	15164-15167	the	_	
101-39	15168-15181	corresponding	_	
101-40	15182-15187	nodes	_	
101-41	15187-15188	,	_	
101-42	15189-15192	and	_	
101-43	15193-15197	vice	_	
101-44	15198-15203	versa	_	
101-45	15203-15204	.	_	

#Text=We use sparsity as a measurement of the threshold T.
102-1	15208-15210	We	_	
102-2	15211-15214	use	_	
102-3	15215-15223	sparsity	_	
102-4	15224-15226	as	_	
102-5	15227-15228	a	_	
102-6	15229-15240	measurement	_	
102-7	15241-15243	of	_	
102-8	15244-15247	the	_	
102-9	15248-15257	threshold	_	
102-10	15258-15259	T	_	
102-11	15259-15260	.	_	

#Text=Sparsity is the ratio of the actual number of edge to the possible maximum number of edge in matrix.
103-1	15261-15269	Sparsity	_	
103-2	15270-15272	is	_	
103-3	15273-15276	the	_	
103-4	15277-15282	ratio	_	
103-5	15283-15285	of	_	
103-6	15286-15289	the	_	
103-7	15290-15296	actual	_	
103-8	15297-15303	number	_	
103-9	15304-15306	of	_	
103-10	15307-15311	edge	_	
103-11	15312-15314	to	_	
103-12	15315-15318	the	_	
103-13	15319-15327	possible	_	
103-14	15328-15335	maximum	_	
103-15	15336-15342	number	_	
103-16	15343-15345	of	_	
103-17	15346-15350	edge	_	
103-18	15351-15353	in	_	
103-19	15354-15360	matrix	_	
103-20	15360-15361	.	_	

#Text=There is no quantitative relationship between sparsity S and threshold T.
104-1	15362-15367	There	_	
104-2	15368-15370	is	_	
104-3	15371-15373	no	_	
104-4	15374-15386	quantitative	_	
104-5	15387-15399	relationship	_	
104-6	15400-15407	between	_	
104-7	15408-15416	sparsity	_	
104-8	15417-15418	S	_	
104-9	15419-15422	and	_	
104-10	15423-15432	threshold	_	
104-11	15433-15434	T	_	
104-12	15434-15435	.	_	

#Text=If the sparsity of the binarized matrix is set to 50%, when binarizing the Pearson correlation matrix, T is the median of the ascending correlation coefficient.
105-1	15436-15438	If	_	
105-2	15439-15442	the	_	
105-3	15443-15451	sparsity	_	
105-4	15452-15454	of	_	
105-5	15455-15458	the	_	
105-6	15459-15468	binarized	_	
105-7	15469-15475	matrix	_	
105-8	15476-15478	is	_	
105-9	15479-15482	set	_	
105-10	15483-15485	to	_	
105-11	15486-15489	50%	_	
105-12	15489-15490	,	_	
105-13	15491-15495	when	_	
105-14	15496-15506	binarizing	_	
105-15	15507-15510	the	_	
105-16	15511-15518	Pearson	_	
105-17	15519-15530	correlation	_	
105-18	15531-15537	matrix	_	
105-19	15537-15538	,	_	
105-20	15539-15540	T	_	
105-21	15541-15543	is	_	
105-22	15544-15547	the	_	
105-23	15548-15554	median	_	
105-24	15555-15557	of	_	
105-25	15558-15561	the	_	
105-26	15562-15571	ascending	_	
105-27	15572-15583	correlation	_	
105-28	15584-15595	coefficient	_	
105-29	15595-15596	.	_	

#Text=When the correlation coefficient is greater than the median, it has edge and vice verse.
106-1	15597-15601	When	_	
106-2	15602-15605	the	_	
106-3	15606-15617	correlation	_	
106-4	15618-15629	coefficient	_	
106-5	15630-15632	is	_	
106-6	15633-15640	greater	_	
106-7	15641-15645	than	_	
106-8	15646-15649	the	_	
106-9	15650-15656	median	_	
106-10	15656-15657	,	_	
106-11	15658-15660	it	_	
106-12	15661-15664	has	_	
106-13	15665-15669	edge	_	
106-14	15670-15673	and	_	
106-15	15674-15678	vice	_	
106-16	15679-15684	verse	_	
106-17	15684-15685	.	_	

#Text=The actual number of edge is just half of the maximum possible one.
107-1	15686-15689	The	_	
107-2	15690-15696	actual	_	
107-3	15697-15703	number	_	
107-4	15704-15706	of	_	
107-5	15707-15711	edge	_	
107-6	15712-15714	is	_	
107-7	15715-15719	just	_	
107-8	15720-15724	half	_	
107-9	15725-15727	of	_	
107-10	15728-15731	the	_	
107-11	15732-15739	maximum	_	
107-12	15740-15748	possible	_	
107-13	15749-15752	one	_	
107-14	15752-15753	.	_	

#Text=In the study of the brain network, most researchers use sparsity with fixed interval to study the topological properties of the brain network with multiple thresholds.
108-1	15754-15756	In	_	
108-2	15757-15760	the	_	
108-3	15761-15766	study	_	
108-4	15767-15769	of	_	
108-5	15770-15773	the	_	
108-6	15774-15779	brain	_	
108-7	15780-15787	network	_	
108-8	15787-15788	,	_	
108-9	15789-15793	most	_	
108-10	15794-15805	researchers	_	
108-11	15806-15809	use	_	
108-12	15810-15818	sparsity	_	
108-13	15819-15823	with	_	
108-14	15824-15829	fixed	_	
108-15	15830-15838	interval	_	
108-16	15839-15841	to	_	
108-17	15842-15847	study	_	
108-18	15848-15851	the	_	
108-19	15852-15863	topological	_	
108-20	15864-15874	properties	_	
108-21	15875-15877	of	_	
108-22	15878-15881	the	_	
108-23	15882-15887	brain	_	
108-24	15888-15895	network	_	
108-25	15896-15900	with	_	
108-26	15901-15909	multiple	_	
108-27	15910-15920	thresholds	_	
108-28	15920-15921	.	_	

#Text=Here we set the sparsity range from 1 to 50% to ensure the sparseness of the network.
109-1	15922-15926	Here	_	
109-2	15927-15929	we	_	
109-3	15930-15933	set	_	
109-4	15934-15937	the	_	
109-5	15938-15946	sparsity	_	
109-6	15947-15952	range	_	
109-7	15953-15957	from	_	
109-8	15958-15959	1	_	
109-9	15960-15962	to	_	
109-10	15963-15966	50%	_	
109-11	15967-15969	to	_	
109-12	15970-15976	ensure	_	
109-13	15977-15980	the	_	
109-14	15981-15991	sparseness	_	
109-15	15992-15994	of	_	
109-16	15995-15998	the	_	
109-17	15999-16006	network	_	
109-18	16006-16007	.	_	

#Text=After binarization, we get the binary matrix which is corresponding to the brain network matrix.
110-1	16008-16013	After	_	
110-2	16014-16026	binarization	_	
110-3	16026-16027	,	_	
110-4	16028-16030	we	_	
110-5	16031-16034	get	_	
110-6	16035-16038	the	_	
110-7	16039-16045	binary	_	
110-8	16046-16052	matrix	_	
110-9	16053-16058	which	_	
110-10	16059-16061	is	_	
110-11	16062-16075	corresponding	_	
110-12	16076-16078	to	_	
110-13	16079-16082	the	_	
110-14	16083-16088	brain	_	
110-15	16089-16096	network	_	
110-16	16097-16103	matrix	_	
110-17	16103-16104	.	_	

#Text=Thus we get the brain network of 76 subjects.
111-1	16105-16109	Thus	_	
111-2	16110-16112	we	_	
111-3	16113-16116	get	_	
111-4	16117-16120	the	_	
111-5	16121-16126	brain	_	
111-6	16127-16134	network	_	
111-7	16135-16137	of	_	
111-8	16138-16140	76	_	
111-9	16141-16149	subjects	_	
111-10	16149-16150	.	_	

#Text=Feature extraction based on CBNA
#Text=Result of eigenvectors constructed with the attribute of node degree when the threshold is set to 0.21
#Text=After get the brain network of 76 subjects, the basic attribute index of the network is calculated by using the formula of basic attribute value in complex network theory.
112-1	16151-16158	Feature	_	
112-2	16159-16169	extraction	_	
112-3	16170-16175	based	_	
112-4	16176-16178	on	_	
112-5	16179-16183	CBNA	_	
112-6	16184-16190	Result	_	
112-7	16191-16193	of	_	
112-8	16194-16206	eigenvectors	_	
112-9	16207-16218	constructed	_	
112-10	16219-16223	with	_	
112-11	16224-16227	the	_	
112-12	16228-16237	attribute	_	
112-13	16238-16240	of	_	
112-14	16241-16245	node	_	
112-15	16246-16252	degree	_	
112-16	16253-16257	when	_	
112-17	16258-16261	the	_	
112-18	16262-16271	threshold	_	
112-19	16272-16274	is	_	
112-20	16275-16278	set	_	
112-21	16279-16281	to	_	
112-22	16282-16286	0.21	_	
112-23	16287-16292	After	_	
112-24	16293-16296	get	_	
112-25	16297-16300	the	_	
112-26	16301-16306	brain	_	
112-27	16307-16314	network	_	
112-28	16315-16317	of	_	
112-29	16318-16320	76	_	
112-30	16321-16329	subjects	_	
112-31	16329-16330	,	_	
112-32	16331-16334	the	_	
112-33	16335-16340	basic	_	
112-34	16341-16350	attribute	_	
112-35	16351-16356	index	_	
112-36	16357-16359	of	_	
112-37	16360-16363	the	_	
112-38	16364-16371	network	_	
112-39	16372-16374	is	_	
112-40	16375-16385	calculated	_	
112-41	16386-16388	by	_	
112-42	16389-16394	using	_	
112-43	16395-16398	the	_	
112-44	16399-16406	formula	_	
112-45	16407-16409	of	_	
112-46	16410-16415	basic	_	
112-47	16416-16425	attribute	_	
112-48	16426-16431	value	_	
112-49	16432-16434	in	_	
112-50	16435-16442	complex	_	
112-51	16443-16450	network	_	
112-52	16451-16457	theory	_	
112-53	16457-16458	.	_	

#Text=The basic attributes we used here are the degree of node, clustering coefficient, local efficiency and global efficiency.
113-1	16459-16462	The	_	
113-2	16463-16468	basic	_	
113-3	16469-16479	attributes	_	
113-4	16480-16482	we	_	
113-5	16483-16487	used	_	
113-6	16488-16492	here	_	
113-7	16493-16496	are	_	
113-8	16497-16500	the	_	
113-9	16501-16507	degree	_	
113-10	16508-16510	of	_	
113-11	16511-16515	node	_	
113-12	16515-16516	,	_	
113-13	16517-16527	clustering	_	
113-14	16528-16539	coefficient	_	
113-15	16539-16540	,	_	
113-16	16541-16546	local	_	
113-17	16547-16557	efficiency	_	
113-18	16558-16561	and	_	
113-19	16562-16568	global	_	
113-20	16569-16579	efficiency	_	
113-21	16579-16580	.	_	

#Text=In this way we get a 52-dimensional eigenvector of the above four attributes.
114-1	16581-16583	In	_	
114-2	16584-16588	this	_	
114-3	16589-16592	way	_	
114-4	16593-16595	we	_	
114-5	16596-16599	get	_	
114-6	16600-16601	a	_	
114-7	16602-16604	52	_	
114-8	16604-16605	-	_	
114-9	16605-16616	dimensional	_	
114-10	16617-16628	eigenvector	_	
114-11	16629-16631	of	_	
114-12	16632-16635	the	_	
114-13	16636-16641	above	_	
114-14	16642-16646	four	_	
114-15	16647-16657	attributes	_	
114-16	16657-16658	.	_	

#Text=Since the threshold is changed from 0.01 to 0.5 with an interval of 0.01, it is necessary to select eigenvector with significant differences in each attribute from the 50 thresholds to make subsequent classification decisions.
115-1	16659-16664	Since	_	
115-2	16665-16668	the	_	
115-3	16669-16678	threshold	_	
115-4	16679-16681	is	_	
115-5	16682-16689	changed	_	
115-6	16690-16694	from	_	
115-7	16695-16699	0.01	_	
115-8	16700-16702	to	_	
115-9	16703-16706	0.5	_	
115-10	16707-16711	with	_	
115-11	16712-16714	an	_	
115-12	16715-16723	interval	_	
115-13	16724-16726	of	_	
115-14	16727-16731	0.01	_	
115-15	16731-16732	,	_	
115-16	16733-16735	it	_	
115-17	16736-16738	is	_	
115-18	16739-16748	necessary	_	
115-19	16749-16751	to	_	
115-20	16752-16758	select	_	
115-21	16759-16770	eigenvector	_	
115-22	16771-16775	with	_	
115-23	16776-16787	significant	_	
115-24	16788-16799	differences	_	
115-25	16800-16802	in	_	
115-26	16803-16807	each	_	
115-27	16808-16817	attribute	_	
115-28	16818-16822	from	_	
115-29	16823-16826	the	_	
115-30	16827-16829	50	_	
115-31	16830-16840	thresholds	_	
115-32	16841-16843	to	_	
115-33	16844-16848	make	_	
115-34	16849-16859	subsequent	_	
115-35	16860-16874	classification	_	
115-36	16875-16884	decisions	_	
115-37	16884-16885	.	_	

#Text=After reduce the dimension of eigenvector of each attribute, we find there is a significant difference of the node degree when the threshold is set to 0.21.
116-1	16886-16891	After	_	
116-2	16892-16898	reduce	_	
116-3	16899-16902	the	_	
116-4	16903-16912	dimension	_	
116-5	16913-16915	of	_	
116-6	16916-16927	eigenvector	_	
116-7	16928-16930	of	_	
116-8	16931-16935	each	_	
116-9	16936-16945	attribute	_	
116-10	16945-16946	,	_	
116-11	16947-16949	we	_	
116-12	16950-16954	find	_	
116-13	16955-16960	there	_	
116-14	16961-16963	is	_	
116-15	16964-16965	a	_	
116-16	16966-16977	significant	_	
116-17	16978-16988	difference	_	
116-18	16989-16991	of	_	
116-19	16992-16995	the	_	
116-20	16996-17000	node	_	
116-21	17001-17007	degree	_	
116-22	17008-17012	when	_	
116-23	17013-17016	the	_	
116-24	17017-17026	threshold	_	
116-25	17027-17029	is	_	
116-26	17030-17033	set	_	
116-27	17034-17036	to	_	
116-28	17037-17041	0.21	_	
116-29	17041-17042	.	_	

#Text=Thus, we choose the attribute of the node degree at threshold 0.21 to construct the final eigenvector.
117-1	17043-17047	Thus	_	
117-2	17047-17048	,	_	
117-3	17049-17051	we	_	
117-4	17052-17058	choose	_	
117-5	17059-17062	the	_	
117-6	17063-17072	attribute	_	
117-7	17073-17075	of	_	
117-8	17076-17079	the	_	
117-9	17080-17084	node	_	
117-10	17085-17091	degree	_	
117-11	17092-17094	at	_	
117-12	17095-17104	threshold	_	
117-13	17105-17109	0.21	_	
117-14	17110-17112	to	_	
117-15	17113-17122	construct	_	
117-16	17123-17126	the	_	
117-17	17127-17132	final	_	
117-18	17133-17144	eigenvector	_	
117-19	17144-17145	.	_	

#Text=Fig. 9 shows the result of eigenvectors constructed with the attribute of node degree when the threshold is 0.21.
118-1	17146-17149	Fig	_	
118-2	17149-17150	.	_	
118-3	17150-17151	 	_	
118-4	17151-17152	9	_	
118-5	17153-17158	shows	_	
118-6	17159-17162	the	_	
118-7	17163-17169	result	_	
118-8	17170-17172	of	_	
118-9	17173-17185	eigenvectors	_	
118-10	17186-17197	constructed	_	
118-11	17198-17202	with	_	
118-12	17203-17206	the	_	
118-13	17207-17216	attribute	_	
118-14	17217-17219	of	_	
118-15	17220-17224	node	_	
118-16	17225-17231	degree	_	
118-17	17232-17236	when	_	
118-18	17237-17240	the	_	
118-19	17241-17250	threshold	_	
118-20	17251-17253	is	_	
118-21	17254-17258	0.21	_	
118-22	17258-17259	.	_	

#Text=It can be seen that the eigenvector between the healthy control and schizophrenic has significance difference.
119-1	17260-17262	It	_	
119-2	17263-17266	can	_	
119-3	17267-17269	be	_	
119-4	17270-17274	seen	_	
119-5	17275-17279	that	_	
119-6	17280-17283	the	_	
119-7	17284-17295	eigenvector	_	
119-8	17296-17303	between	_	
119-9	17304-17307	the	_	
119-10	17308-17315	healthy	_	
119-11	17316-17323	control	_	
119-12	17324-17327	and	_	
119-13	17328-17341	schizophrenic	_	
119-14	17342-17345	has	_	
119-15	17346-17358	significance	_	
119-16	17359-17369	difference	_	
119-17	17369-17370	.	_	

#Text=SVM-based classifier
#Text=The SVM is a learning machine for a two-class classification problem.
120-1	17373-17382	SVM-based	_	
120-2	17383-17393	classifier	_	
120-3	17394-17397	The	_	
120-4	17398-17401	SVM	_	
120-5	17402-17404	is	_	
120-6	17405-17406	a	_	
120-7	17407-17415	learning	_	
120-8	17416-17423	machine	_	
120-9	17424-17427	for	_	
120-10	17428-17429	a	_	
120-11	17430-17439	two-class	_	
120-12	17440-17454	classification	_	
120-13	17455-17462	problem	_	
120-14	17462-17463	.	_	

#Text=It is proposed by Vapnik as an extension of statistical learning theory.
121-1	17464-17466	It	_	
121-2	17467-17469	is	_	
121-3	17470-17478	proposed	_	
121-4	17479-17481	by	_	
121-5	17482-17488	Vapnik	_	
121-6	17489-17491	as	_	
121-7	17492-17494	an	_	
121-8	17495-17504	extension	_	
121-9	17505-17507	of	_	
121-10	17508-17519	statistical	_	
121-11	17520-17528	learning	_	
121-12	17529-17535	theory	_	
121-13	17535-17536	.	_	

#Text=Due to its ability to handle high-dimensional data and could acquire high accuracy in the classification, SVM has been widely used in many areas.
122-1	17537-17540	Due	_	
122-2	17541-17543	to	_	
122-3	17544-17547	its	_	
122-4	17548-17555	ability	_	
122-5	17556-17558	to	_	
122-6	17559-17565	handle	_	
122-7	17566-17582	high-dimensional	_	
122-8	17583-17587	data	_	
122-9	17588-17591	and	_	
122-10	17592-17597	could	_	
122-11	17598-17605	acquire	_	
122-12	17606-17610	high	_	
122-13	17611-17619	accuracy	_	
122-14	17620-17622	in	_	
122-15	17623-17626	the	_	
122-16	17627-17641	classification	_	
122-17	17641-17642	,	_	
122-18	17643-17646	SVM	_	
122-19	17647-17650	has	_	
122-20	17651-17655	been	_	
122-21	17656-17662	widely	_	
122-22	17663-17667	used	_	
122-23	17668-17670	in	_	
122-24	17671-17675	many	_	
122-25	17676-17681	areas	_	
122-26	17681-17682	.	_	

#Text=SVM conceptually implements the idea that vectors are non-linearly mapped to a high dimension feature space.
123-1	17683-17686	SVM	_	
123-2	17687-17699	conceptually	_	
123-3	17700-17710	implements	_	
123-4	17711-17714	the	_	
123-5	17715-17719	idea	_	
123-6	17720-17724	that	_	
123-7	17725-17732	vectors	_	
123-8	17733-17736	are	_	
123-9	17737-17749	non-linearly	_	
123-10	17750-17756	mapped	_	
123-11	17757-17759	to	_	
123-12	17760-17761	a	_	
123-13	17762-17766	high	_	
123-14	17767-17776	dimension	_	
123-15	17777-17784	feature	_	
123-16	17785-17790	space	_	
123-17	17790-17791	.	_	

#Text=In the feature space, a linear separation surface is created to separate the training data by minimizing the margin between the vectors of the two classes.
124-1	17792-17794	In	_	
124-2	17795-17798	the	_	
124-3	17799-17806	feature	_	
124-4	17807-17812	space	_	
124-5	17812-17813	,	_	
124-6	17814-17815	a	_	
124-7	17816-17822	linear	_	
124-8	17823-17833	separation	_	
124-9	17834-17841	surface	_	
124-10	17842-17844	is	_	
124-11	17845-17852	created	_	
124-12	17853-17855	to	_	
124-13	17856-17864	separate	_	
124-14	17865-17868	the	_	
124-15	17869-17877	training	_	
124-16	17878-17882	data	_	
124-17	17883-17885	by	_	
124-18	17886-17896	minimizing	_	
124-19	17897-17900	the	_	
124-20	17901-17907	margin	_	
124-21	17908-17915	between	_	
124-22	17916-17919	the	_	
124-23	17920-17927	vectors	_	
124-24	17928-17930	of	_	
124-25	17931-17934	the	_	
124-26	17935-17938	two	_	
124-27	17939-17946	classes	_	
124-28	17946-17947	.	_	

#Text=The training ends with the definition of a decision surface that divides the space into two sub-spaces.
125-1	17948-17951	The	_	
125-2	17952-17960	training	_	
125-3	17961-17965	ends	_	
125-4	17966-17970	with	_	
125-5	17971-17974	the	_	
125-6	17975-17985	definition	_	
125-7	17986-17988	of	_	
125-8	17989-17990	a	_	
125-9	17991-17999	decision	_	
125-10	18000-18007	surface	_	
125-11	18008-18012	that	_	
125-12	18013-18020	divides	_	
125-13	18021-18024	the	_	
125-14	18025-18030	space	_	
125-15	18031-18035	into	_	
125-16	18036-18039	two	_	
125-17	18040-18050	sub-spaces	_	
125-18	18050-18051	.	_	

#Text=Each sub-space corresponds to one class of the training data.
126-1	18052-18056	Each	_	
126-2	18057-18066	sub-space	_	
126-3	18067-18078	corresponds	_	
126-4	18079-18081	to	_	
126-5	18082-18085	one	_	
126-6	18086-18091	class	_	
126-7	18092-18094	of	_	
126-8	18095-18098	the	_	
126-9	18099-18107	training	_	
126-10	18108-18112	data	_	
126-11	18112-18113	.	_	

#Text=Once the training is completed, the test data are mapped to the feature space.
127-1	18114-18118	Once	_	
127-2	18119-18122	the	_	
127-3	18123-18131	training	_	
127-4	18132-18134	is	_	
127-5	18135-18144	completed	_	
127-6	18144-18145	,	_	
127-7	18146-18149	the	_	
127-8	18150-18154	test	_	
127-9	18155-18159	data	_	
127-10	18160-18163	are	_	
127-11	18164-18170	mapped	_	
127-12	18171-18173	to	_	
127-13	18174-18177	the	_	
127-14	18178-18185	feature	_	
127-15	18186-18191	space	_	
127-16	18191-18192	.	_	

#Text=A class is then assigned to the test data depending on which sub-space they are mapped to.
128-1	18193-18194	A	_	
128-2	18195-18200	class	_	
128-3	18201-18203	is	_	
128-4	18204-18208	then	_	
128-5	18209-18217	assigned	_	
128-6	18218-18220	to	_	
128-7	18221-18224	the	_	
128-8	18225-18229	test	_	
128-9	18230-18234	data	_	
128-10	18235-18244	depending	_	
128-11	18245-18247	on	_	
128-12	18248-18253	which	_	
128-13	18254-18263	sub-space	_	
128-14	18264-18268	they	_	
128-15	18269-18272	are	_	
128-16	18273-18279	mapped	_	
128-17	18280-18282	to	_	
128-18	18282-18283	.	_	

#Text=In this paper, a SVM toolkit named libsvm written by Lin Chih-Jen from Taiwan University is used.
129-1	18284-18286	In	_	
129-2	18287-18291	this	_	
129-3	18292-18297	paper	_	
129-4	18297-18298	,	_	
129-5	18299-18300	a	_	
129-6	18301-18304	SVM	_	
129-7	18305-18312	toolkit	_	
129-8	18313-18318	named	_	
129-9	18319-18325	libsvm	_	
129-10	18326-18333	written	_	
129-11	18334-18336	by	_	
129-12	18337-18340	Lin	_	
129-13	18341-18349	Chih-Jen	_	
129-14	18350-18354	from	_	
129-15	18355-18361	Taiwan	_	
129-16	18362-18372	University	_	
129-17	18373-18375	is	_	
129-18	18376-18380	used	_	
129-19	18380-18381	.	_	

#Text=A radial basis function is selected as a kernel function and parameters are kept as default values.
130-1	18382-18383	A	_	
130-2	18384-18390	radial	_	
130-3	18391-18396	basis	_	
130-4	18397-18405	function	_	
130-5	18406-18408	is	_	
130-6	18409-18417	selected	_	
130-7	18418-18420	as	_	
130-8	18421-18422	a	_	
130-9	18423-18429	kernel	_	
130-10	18430-18438	function	_	
130-11	18439-18442	and	_	
130-12	18443-18453	parameters	_	
130-13	18454-18457	are	_	
130-14	18458-18462	kept	_	
130-15	18463-18465	as	_	
130-16	18466-18473	default	_	
130-17	18474-18480	values	_	
130-18	18480-18481	.	_	

#Text=Cross validation is frequently used in classification problems, which mainly divided into K fold cross validation and the leave-one-out cross validation.
131-1	18482-18487	Cross	_	
131-2	18488-18498	validation	_	
131-3	18499-18501	is	_	
131-4	18502-18512	frequently	_	
131-5	18513-18517	used	_	
131-6	18518-18520	in	_	
131-7	18521-18535	classification	_	
131-8	18536-18544	problems	_	
131-9	18544-18545	,	_	
131-10	18546-18551	which	_	
131-11	18552-18558	mainly	_	
131-12	18559-18566	divided	_	
131-13	18567-18571	into	_	
131-14	18572-18573	K	_	
131-15	18574-18578	fold	_	
131-16	18579-18584	cross	_	
131-17	18585-18595	validation	_	
131-18	18596-18599	and	_	
131-19	18600-18603	the	_	
131-20	18604-18617	leave-one-out	_	
131-21	18618-18623	cross	_	
131-22	18624-18634	validation	_	
131-23	18634-18635	.	_	

#Text=Here we use the leave-one-out cross validation to evaluate the classification result.
132-1	18636-18640	Here	_	
132-2	18641-18643	we	_	
132-3	18644-18647	use	_	
132-4	18648-18651	the	_	
132-5	18652-18665	leave-one-out	_	
132-6	18666-18671	cross	_	
132-7	18672-18682	validation	_	
132-8	18683-18685	to	_	
132-9	18686-18694	evaluate	_	
132-10	18695-18698	the	_	
132-11	18699-18713	classification	_	
132-12	18714-18720	result	_	
132-13	18720-18721	.	_	

#Text=Suppose there are N samples, leave-one-out cross validation continues N rounds, each round one sample will be as a test sample, the rest N−1 samples are as the training sample.
133-1	18722-18729	Suppose	_	
133-2	18730-18735	there	_	
133-3	18736-18739	are	_	
133-4	18740-18741	N	_	
133-5	18742-18749	samples	_	
133-6	18749-18750	,	_	
133-7	18751-18764	leave-one-out	_	
133-8	18765-18770	cross	_	
133-9	18771-18781	validation	_	
133-10	18782-18791	continues	_	
133-11	18792-18793	N	_	
133-12	18794-18800	rounds	_	
133-13	18800-18801	,	_	
133-14	18802-18806	each	_	
133-15	18807-18812	round	_	
133-16	18813-18816	one	_	
133-17	18817-18823	sample	_	
133-18	18824-18828	will	_	
133-19	18829-18831	be	_	
133-20	18832-18834	as	_	
133-21	18835-18836	a	_	
133-22	18837-18841	test	_	
133-23	18842-18848	sample	_	
133-24	18848-18849	,	_	
133-25	18850-18853	the	_	
133-26	18854-18858	rest	_	
133-27	18859-18860	N	_	
133-28	18860-18861	−	_	
133-29	18861-18862	1	_	
133-30	18863-18870	samples	_	
133-31	18871-18874	are	_	
133-32	18875-18877	as	_	
133-33	18878-18881	the	_	
133-34	18882-18890	training	_	
133-35	18891-18897	sample	_	
133-36	18897-18898	.	_	

#Text=After N rounds of cross validation, each round will get a classification accuracy.
134-1	18899-18904	After	_	
134-2	18905-18906	N	_	
134-3	18907-18913	rounds	_	
134-4	18914-18916	of	_	
134-5	18917-18922	cross	_	
134-6	18923-18933	validation	_	
134-7	18933-18934	,	_	
134-8	18935-18939	each	_	
134-9	18940-18945	round	_	
134-10	18946-18950	will	_	
134-11	18951-18954	get	_	
134-12	18955-18956	a	_	
134-13	18957-18971	classification	_	
134-14	18972-18980	accuracy	_	
134-15	18980-18981	.	_	

#Text=Finally, the average classification accuracy will be acquired for N rounds. leave-one-out cross validation can effectively reduce the classification accuracy error caused by the inefficient sample.
135-1	18982-18989	Finally	_	
135-2	18989-18990	,	_	
135-3	18991-18994	the	_	
135-4	18995-19002	average	_	
135-5	19003-19017	classification	_	
135-6	19018-19026	accuracy	_	
135-7	19027-19031	will	_	
135-8	19032-19034	be	_	
135-9	19035-19043	acquired	_	
135-10	19044-19047	for	_	
135-11	19048-19049	N	_	
135-12	19050-19056	rounds	_	
135-13	19056-19057	.	_	
135-14	19058-19071	leave-one-out	_	
135-15	19072-19077	cross	_	
135-16	19078-19088	validation	_	
135-17	19089-19092	can	_	
135-18	19093-19104	effectively	_	
135-19	19105-19111	reduce	_	
135-20	19112-19115	the	_	
135-21	19116-19130	classification	_	
135-22	19131-19139	accuracy	_	
135-23	19140-19145	error	_	
135-24	19146-19152	caused	_	
135-25	19153-19155	by	_	
135-26	19156-19159	the	_	
135-27	19160-19171	inefficient	_	
135-28	19172-19178	sample	_	
135-29	19178-19179	.	_	

#Text=Here the dataset we used include 34 healthy persons and 42 schizophrenic patients.
136-1	19180-19184	Here	_	
136-2	19185-19188	the	_	
136-3	19189-19196	dataset	_	
136-4	19197-19199	we	_	
136-5	19200-19204	used	_	
136-6	19205-19212	include	_	
136-7	19213-19215	34	_	
136-8	19216-19223	healthy	_	
136-9	19224-19231	persons	_	
136-10	19232-19235	and	_	
136-11	19236-19238	42	_	
136-12	19239-19252	schizophrenic	_	
136-13	19253-19261	patients	_	
136-14	19261-19262	.	_	

#Text=In the leave-one-out cross validation, the dataset is separated into 76 samples, every sample will be as a test sample and the rest 75 samples will be a training set, continues 76 rounds.
137-1	19263-19265	In	_	
137-2	19266-19269	the	_	
137-3	19270-19283	leave-one-out	_	
137-4	19284-19289	cross	_	
137-5	19290-19300	validation	_	
137-6	19300-19301	,	_	
137-7	19302-19305	the	_	
137-8	19306-19313	dataset	_	
137-9	19314-19316	is	_	
137-10	19317-19326	separated	_	
137-11	19327-19331	into	_	
137-12	19332-19334	76	_	
137-13	19335-19342	samples	_	
137-14	19342-19343	,	_	
137-15	19344-19349	every	_	
137-16	19350-19356	sample	_	
137-17	19357-19361	will	_	
137-18	19362-19364	be	_	
137-19	19365-19367	as	_	
137-20	19368-19369	a	_	
137-21	19370-19374	test	_	
137-22	19375-19381	sample	_	
137-23	19382-19385	and	_	
137-24	19386-19389	the	_	
137-25	19390-19394	rest	_	
137-26	19395-19397	75	_	
137-27	19398-19405	samples	_	
137-28	19406-19410	will	_	
137-29	19411-19413	be	_	
137-30	19414-19415	a	_	
137-31	19416-19424	training	_	
137-32	19425-19428	set	_	
137-33	19428-19429	,	_	
137-34	19430-19439	continues	_	
137-35	19440-19442	76	_	
137-36	19443-19449	rounds	_	
137-37	19449-19450	.	_	

#Text=Results and discussion
#Text=The finally testing result
#Text=\tClassification accuracy\tSpecificity\tSensitivity\t \tOxy-Hb\t85.5%\t76.5%\t92.8%\t \tDeoxy-Hb\t85.5%\t76.5%\t92.8%\t \tTotal\t80.3%\t64.7%\t92.8%\t \t
#Text=The testing result of schizophrenics and healthy controls is shown in Table 1, where 39 of the 42 schizophrenia and 26 of 34 health controls were discriminated successfully on Oxy-Hb/Deoxy-Hb signal.
138-1	19451-19458	Results	_	
138-2	19459-19462	and	_	
138-3	19463-19473	discussion	_	
138-4	19474-19477	The	_	
138-5	19478-19485	finally	_	
138-6	19486-19493	testing	_	
138-7	19494-19500	result	_	
138-8	19502-19516	Classification	_	
138-9	19517-19525	accuracy	_	
138-10	19526-19537	Specificity	_	
138-11	19538-19549	Sensitivity	_	
138-12	19552-19558	Oxy-Hb	_	
138-13	19559-19564	85.5%	_	
138-14	19565-19570	76.5%	_	
138-15	19571-19576	92.8%	_	
138-16	19579-19587	Deoxy-Hb	_	
138-17	19588-19593	85.5%	_	
138-18	19594-19599	76.5%	_	
138-19	19600-19605	92.8%	_	
138-20	19608-19613	Total	_	
138-21	19614-19619	80.3%	_	
138-22	19620-19625	64.7%	_	
138-23	19626-19631	92.8%	_	
138-24	19635-19638	The	_	
138-25	19639-19646	testing	_	
138-26	19647-19653	result	_	
138-27	19654-19656	of	_	
138-28	19657-19671	schizophrenics	_	
138-29	19672-19675	and	_	
138-30	19676-19683	healthy	_	
138-31	19684-19692	controls	_	
138-32	19693-19695	is	_	
138-33	19696-19701	shown	_	
138-34	19702-19704	in	_	
138-35	19705-19710	Table	_	
138-36	19710-19711	 	_	
138-37	19711-19712	1	_	
138-38	19712-19713	,	_	
138-39	19714-19719	where	_	
138-40	19720-19722	39	_	
138-41	19723-19725	of	_	
138-42	19726-19729	the	_	
138-43	19730-19732	42	_	
138-44	19733-19746	schizophrenia	_	
138-45	19747-19750	and	_	
138-46	19751-19753	26	_	
138-47	19754-19756	of	_	
138-48	19757-19759	34	_	
138-49	19760-19766	health	_	
138-50	19767-19775	controls	_	
138-51	19776-19780	were	_	
138-52	19781-19794	discriminated	_	
138-53	19795-19807	successfully	_	
138-54	19808-19810	on	_	
138-55	19811-19817	Oxy-Hb	_	
138-56	19817-19818	/	_	
138-57	19818-19826	Deoxy-Hb	_	
138-58	19827-19833	signal	_	
138-59	19833-19834	.	_	

#Text=The method based on CBNA and SVM successfully discriminated 65 (39 schizophrenia and 26 healthy persons) signals with an overall accuracy of 85.5% for fNIRS classification on testing set.
139-1	19835-19838	The	_	
139-2	19839-19845	method	_	
139-3	19846-19851	based	_	
139-4	19852-19854	on	_	
139-5	19855-19859	CBNA	_	
139-6	19860-19863	and	_	
139-7	19864-19867	SVM	_	
139-8	19868-19880	successfully	_	
139-9	19881-19894	discriminated	_	
139-10	19895-19897	65	_	
139-11	19898-19899	(	_	
139-12	19899-19901	39	_	
139-13	19902-19915	schizophrenia	_	
139-14	19916-19919	and	_	
139-15	19920-19922	26	_	
139-16	19923-19930	healthy	_	
139-17	19931-19938	persons	_	
139-18	19938-19939	)	_	
139-19	19940-19947	signals	_	
139-20	19948-19952	with	_	
139-21	19953-19955	an	_	
139-22	19956-19963	overall	_	
139-23	19964-19972	accuracy	_	
139-24	19973-19975	of	_	
139-25	19976-19981	85.5%	_	
139-26	19982-19985	for	_	
139-27	19986-19991	fNIRS	_	
139-28	19992-20006	classification	_	
139-29	20007-20009	on	_	
139-30	20010-20017	testing	_	
139-31	20018-20021	set	_	
139-32	20021-20022	.	_	

#Text=And on total signal, where 39 of the 42 schizophrenia and 22 of 34 health controls were discriminated successfully.
140-1	20023-20026	And	_	
140-2	20027-20029	on	_	
140-3	20030-20035	total	_	
140-4	20036-20042	signal	_	
140-5	20042-20043	,	_	
140-6	20044-20049	where	_	
140-7	20050-20052	39	_	
140-8	20053-20055	of	_	
140-9	20056-20059	the	_	
140-10	20060-20062	42	_	
140-11	20063-20076	schizophrenia	_	
140-12	20077-20080	and	_	
140-13	20081-20083	22	_	
140-14	20084-20086	of	_	
140-15	20087-20089	34	_	
140-16	20090-20096	health	_	
140-17	20097-20105	controls	_	
140-18	20106-20110	were	_	
140-19	20111-20124	discriminated	_	
140-20	20125-20137	successfully	_	
140-21	20137-20138	.	_	

#Text=The method successfully discriminated 61 (39 schizophrenia and 22 healthy persons) signals with an overall accuracy of 80.3%.
141-1	20139-20142	The	_	
141-2	20143-20149	method	_	
141-3	20150-20162	successfully	_	
141-4	20163-20176	discriminated	_	
141-5	20177-20179	61	_	
141-6	20180-20181	(	_	
141-7	20181-20183	39	_	
141-8	20184-20197	schizophrenia	_	
141-9	20198-20201	and	_	
141-10	20202-20204	22	_	
141-11	20205-20212	healthy	_	
141-12	20213-20220	persons	_	
141-13	20220-20221	)	_	
141-14	20222-20229	signals	_	
141-15	20230-20234	with	_	
141-16	20235-20237	an	_	
141-17	20238-20245	overall	_	
141-18	20246-20254	accuracy	_	
141-19	20255-20257	of	_	
141-20	20258-20263	80.3%	_	
141-21	20263-20264	.	_	

#Text=Our study was a binary classification, and we first defined the class of schizophrenia patient as positive and the class of healthy control as negative.
142-1	20267-20270	Our	_	
142-2	20271-20276	study	_	
142-3	20277-20280	was	_	
142-4	20281-20282	a	_	
142-5	20283-20289	binary	_	
142-6	20290-20304	classification	_	
142-7	20304-20305	,	_	
142-8	20306-20309	and	_	
142-9	20310-20312	we	_	
142-10	20313-20318	first	_	
142-11	20319-20326	defined	_	
142-12	20327-20330	the	_	
142-13	20331-20336	class	_	
142-14	20337-20339	of	_	
142-15	20340-20353	schizophrenia	_	
142-16	20354-20361	patient	_	
142-17	20362-20364	as	_	
142-18	20365-20373	positive	_	
142-19	20374-20377	and	_	
142-20	20378-20381	the	_	
142-21	20382-20387	class	_	
142-22	20388-20390	of	_	
142-23	20391-20398	healthy	_	
142-24	20399-20406	control	_	
142-25	20407-20409	as	_	
142-26	20410-20418	negative	_	
142-27	20418-20419	.	_	

#Text=Then, TP is the number of schizophrenia patients correctly predicted; TN is the number of healthy controls correctly predicted; FP is the number of healthy controls classified as schizophrenia patients; and the FN is the number of schizophrenia patients classified as healthy controls.
143-1	20420-20424	Then	_	
143-2	20424-20425	,	_	
143-3	20426-20428	TP	_	
143-4	20429-20431	is	_	
143-5	20432-20435	the	_	
143-6	20436-20442	number	_	
143-7	20443-20445	of	_	
143-8	20446-20459	schizophrenia	_	
143-9	20460-20468	patients	_	
143-10	20469-20478	correctly	_	
143-11	20479-20488	predicted	_	
143-12	20488-20489	;	_	
143-13	20490-20492	TN	_	
143-14	20493-20495	is	_	
143-15	20496-20499	the	_	
143-16	20500-20506	number	_	
143-17	20507-20509	of	_	
143-18	20510-20517	healthy	_	
143-19	20518-20526	controls	_	
143-20	20527-20536	correctly	_	
143-21	20537-20546	predicted	_	
143-22	20546-20547	;	_	
143-23	20548-20550	FP	_	
143-24	20551-20553	is	_	
143-25	20554-20557	the	_	
143-26	20558-20564	number	_	
143-27	20565-20567	of	_	
143-28	20568-20575	healthy	_	
143-29	20576-20584	controls	_	
143-30	20585-20595	classified	_	
143-31	20596-20598	as	_	
143-32	20599-20612	schizophrenia	_	
143-33	20613-20621	patients	_	
143-34	20621-20622	;	_	
143-35	20623-20626	and	_	
143-36	20627-20630	the	_	
143-37	20631-20633	FN	_	
143-38	20634-20636	is	_	
143-39	20637-20640	the	_	
143-40	20641-20647	number	_	
143-41	20648-20650	of	_	
143-42	20651-20664	schizophrenia	_	
143-43	20665-20673	patients	_	
143-44	20674-20684	classified	_	
143-45	20685-20687	as	_	
143-46	20688-20695	healthy	_	
143-47	20696-20704	controls	_	
143-48	20704-20705	.	_	

#Text=Finally, the performance of a classifier can be quantified by using the ACC, SS and specificity or TNR; These measures are defined as follows:   
#Text=ACC represents the ration between correctly classified samples and total samples.
144-1	20706-20713	Finally	_	
144-2	20713-20714	,	_	
144-3	20715-20718	the	_	
144-4	20719-20730	performance	_	
144-5	20731-20733	of	_	
144-6	20734-20735	a	_	
144-7	20736-20746	classifier	_	
144-8	20747-20750	can	_	
144-9	20751-20753	be	_	
144-10	20754-20764	quantified	_	
144-11	20765-20767	by	_	
144-12	20768-20773	using	_	
144-13	20774-20777	the	_	
144-14	20778-20781	ACC	_	
144-15	20781-20782	,	_	
144-16	20783-20785	SS	_	
144-17	20786-20789	and	_	
144-18	20790-20801	specificity	_	
144-19	20802-20804	or	_	
144-20	20805-20808	TNR	_	
144-21	20808-20809	;	_	
144-22	20810-20815	These	_	
144-23	20816-20824	measures	_	
144-24	20825-20828	are	_	
144-25	20829-20836	defined	_	
144-26	20837-20839	as	_	
144-27	20840-20847	follows	_	
144-28	20847-20848	:	_	
144-29	20852-20855	ACC	_	
144-30	20856-20866	represents	_	
144-31	20867-20870	the	_	
144-32	20871-20877	ration	_	
144-33	20878-20885	between	_	
144-34	20886-20895	correctly	_	
144-35	20896-20906	classified	_	
144-36	20907-20914	samples	_	
144-37	20915-20918	and	_	
144-38	20919-20924	total	_	
144-39	20925-20932	samples	_	
144-40	20932-20933	.	_	

#Text=SS represents the ratio between correctly classified schizophrenic patients and total schizophrenic patients.
145-1	20934-20936	SS	_	
145-2	20937-20947	represents	_	
145-3	20948-20951	the	_	
145-4	20952-20957	ratio	_	
145-5	20958-20965	between	_	
145-6	20966-20975	correctly	_	
145-7	20976-20986	classified	_	
145-8	20987-21000	schizophrenic	_	
145-9	21001-21009	patients	_	
145-10	21010-21013	and	_	
145-11	21014-21019	total	_	
145-12	21020-21033	schizophrenic	_	
145-13	21034-21042	patients	_	
145-14	21042-21043	.	_	

#Text=TNR represents the ratio between correctly classified health controls and total health controls.
146-1	21044-21047	TNR	_	
146-2	21048-21058	represents	_	
146-3	21059-21062	the	_	
146-4	21063-21068	ratio	_	
146-5	21069-21076	between	_	
146-6	21077-21086	correctly	_	
146-7	21087-21097	classified	_	
146-8	21098-21104	health	_	
146-9	21105-21113	controls	_	
146-10	21114-21117	and	_	
146-11	21118-21123	total	_	
146-12	21124-21130	health	_	
146-13	21131-21139	controls	_	
146-14	21139-21140	.	_	

#Text=Therefore, a good fNIRS-aided diagnostic classifier is assumed to have larger ACC and TNR values.
147-1	21141-21150	Therefore	_	
147-2	21150-21151	,	_	
147-3	21152-21153	a	_	
147-4	21154-21158	good	_	
147-5	21159-21170	fNIRS-aided	_	
147-6	21171-21181	diagnostic	_	
147-7	21182-21192	classifier	_	
147-8	21193-21195	is	_	
147-9	21196-21203	assumed	_	
147-10	21204-21206	to	_	
147-11	21207-21211	have	_	
147-12	21212-21218	larger	_	
147-13	21219-21222	ACC	_	
147-14	21223-21226	and	_	
147-15	21227-21230	TNR	_	
147-16	21231-21237	values	_	
147-17	21237-21238	.	_	

#Text=Testing result of schizophrenic and healthy on Oxy-Hb signal
#Text=CBNA+SVM\t\t\tClassified results\t \t\t\t\t1(Schizophrenia)\t-1(healthy)\t \t\t\t\t47\t29\t \tData set\t1(Schizophrenia)\t42\t39\t3\t \t\t-1(healthy)\t34\t8\t26\t \tAccuracy of schizophrenia (SS)\t39/42=92.8%\t \tAccuracy of healthy((TNR))\t26/34=76.5%\t \tClassification accuracy(ACC)\t65/76=85.5%\t \t
#Text=Testing result of schizophrenic and healthy on total signal
#Text=CBNA+SVM\t\t\tClassified results\t \t\t\t\t1(Schizophrenia)\t-1(healthy)\t \t\t\t\t61\t25\t \tData set\t1(Schizophrenia)\t42\t39\t3\t \t\t-1(healthy)\t34\t12\t22\t \tAccuracy of schizophrenia (SS)\t39/42=92.8%\t \tAccuracy of healthy((TNR))\t22/34=64.7%\t \tClassification accuracy(ACC)\t61/76=80.3%\t \t
#Text=After 76 rounds of cross validation, there are totally 11 misclassified cases on Oxy-Hb signal.
148-1	21239-21246	Testing	_	
148-2	21247-21253	result	_	
148-3	21254-21256	of	_	
148-4	21257-21270	schizophrenic	_	
148-5	21271-21274	and	_	
148-6	21275-21282	healthy	_	
148-7	21283-21285	on	_	
148-8	21286-21292	Oxy-Hb	_	
148-9	21293-21299	signal	_	
148-10	21300-21304	CBNA	_	
148-11	21304-21305	+	_	
148-12	21305-21308	SVM	_	
148-13	21311-21321	Classified	_	
148-14	21322-21329	results	_	
148-15	21335-21336	1	_	
148-16	21336-21337	(	_	
148-17	21337-21350	Schizophrenia	_	
148-18	21350-21351	)	_	
148-19	21352-21353	-	_	
148-20	21353-21354	1	_	
148-21	21354-21355	(	_	
148-22	21355-21362	healthy	_	
148-23	21362-21363	)	_	
148-24	21369-21371	47	_	
148-25	21372-21374	29	_	
148-26	21377-21381	Data	_	
148-27	21382-21385	set	_	
148-28	21386-21387	1	_	
148-29	21387-21388	(	_	
148-30	21388-21401	Schizophrenia	_	
148-31	21401-21402	)	_	
148-32	21403-21405	42	_	
148-33	21406-21408	39	_	
148-34	21409-21410	3	_	
148-35	21414-21415	-	_	
148-36	21415-21416	1	_	
148-37	21416-21417	(	_	
148-38	21417-21424	healthy	_	
148-39	21424-21425	)	_	
148-40	21426-21428	34	_	
148-41	21429-21430	8	_	
148-42	21431-21433	26	_	
148-43	21436-21444	Accuracy	_	
148-44	21445-21447	of	_	
148-45	21448-21461	schizophrenia	_	
148-46	21462-21463	(	_	
148-47	21463-21465	SS	_	
148-48	21465-21466	)	_	
148-49	21467-21469	39	_	
148-50	21469-21470	/	_	
148-51	21470-21472	42	_	
148-52	21472-21473	=	_	
148-53	21473-21478	92.8%	_	
148-54	21481-21489	Accuracy	_	
148-55	21490-21492	of	_	
148-56	21493-21500	healthy	_	
148-57	21500-21501	(	_	
148-58	21501-21502	(	_	
148-59	21502-21505	TNR	_	
148-60	21505-21506	)	_	
148-61	21506-21507	)	_	
148-62	21508-21510	26	_	
148-63	21510-21511	/	_	
148-64	21511-21513	34	_	
148-65	21513-21514	=	_	
148-66	21514-21519	76.5%	_	
148-67	21522-21536	Classification	_	
148-68	21537-21545	accuracy	_	
148-69	21545-21546	(	_	
148-70	21546-21549	ACC	_	
148-71	21549-21550	)	_	
148-72	21551-21553	65	_	
148-73	21553-21554	/	_	
148-74	21554-21556	76	_	
148-75	21556-21557	=	_	
148-76	21557-21562	85.5%	_	
148-77	21566-21573	Testing	_	
148-78	21574-21580	result	_	
148-79	21581-21583	of	_	
148-80	21584-21597	schizophrenic	_	
148-81	21598-21601	and	_	
148-82	21602-21609	healthy	_	
148-83	21610-21612	on	_	
148-84	21613-21618	total	_	
148-85	21619-21625	signal	_	
148-86	21626-21630	CBNA	_	
148-87	21630-21631	+	_	
148-88	21631-21634	SVM	_	
148-89	21637-21647	Classified	_	
148-90	21648-21655	results	_	
148-91	21661-21662	1	_	
148-92	21662-21663	(	_	
148-93	21663-21676	Schizophrenia	_	
148-94	21676-21677	)	_	
148-95	21678-21679	-	_	
148-96	21679-21680	1	_	
148-97	21680-21681	(	_	
148-98	21681-21688	healthy	_	
148-99	21688-21689	)	_	
148-100	21695-21697	61	_	
148-101	21698-21700	25	_	
148-102	21703-21707	Data	_	
148-103	21708-21711	set	_	
148-104	21712-21713	1	_	
148-105	21713-21714	(	_	
148-106	21714-21727	Schizophrenia	_	
148-107	21727-21728	)	_	
148-108	21729-21731	42	_	
148-109	21732-21734	39	_	
148-110	21735-21736	3	_	
148-111	21740-21741	-	_	
148-112	21741-21742	1	_	
148-113	21742-21743	(	_	
148-114	21743-21750	healthy	_	
148-115	21750-21751	)	_	
148-116	21752-21754	34	_	
148-117	21755-21757	12	_	
148-118	21758-21760	22	_	
148-119	21763-21771	Accuracy	_	
148-120	21772-21774	of	_	
148-121	21775-21788	schizophrenia	_	
148-122	21789-21790	(	_	
148-123	21790-21792	SS	_	
148-124	21792-21793	)	_	
148-125	21794-21796	39	_	
148-126	21796-21797	/	_	
148-127	21797-21799	42	_	
148-128	21799-21800	=	_	
148-129	21800-21805	92.8%	_	
148-130	21808-21816	Accuracy	_	
148-131	21817-21819	of	_	
148-132	21820-21827	healthy	_	
148-133	21827-21828	(	_	
148-134	21828-21829	(	_	
148-135	21829-21832	TNR	_	
148-136	21832-21833	)	_	
148-137	21833-21834	)	_	
148-138	21835-21837	22	_	
148-139	21837-21838	/	_	
148-140	21838-21840	34	_	
148-141	21840-21841	=	_	
148-142	21841-21846	64.7%	_	
148-143	21849-21863	Classification	_	
148-144	21864-21872	accuracy	_	
148-145	21872-21873	(	_	
148-146	21873-21876	ACC	_	
148-147	21876-21877	)	_	
148-148	21878-21880	61	_	
148-149	21880-21881	/	_	
148-150	21881-21883	76	_	
148-151	21883-21884	=	_	
148-152	21884-21889	80.3%	_	
148-153	21893-21898	After	_	
148-154	21899-21901	76	_	
148-155	21902-21908	rounds	_	
148-156	21909-21911	of	_	
148-157	21912-21917	cross	_	
148-158	21918-21928	validation	_	
148-159	21928-21929	,	_	
148-160	21930-21935	there	_	
148-161	21936-21939	are	_	
148-162	21940-21947	totally	_	
148-163	21948-21950	11	_	
148-164	21951-21964	misclassified	_	
148-165	21965-21970	cases	_	
148-166	21971-21973	on	_	
148-167	21974-21980	Oxy-Hb	_	
148-168	21981-21987	signal	_	
148-169	21987-21988	.	_	

#Text=Including 8 cases of normal people and 3 cases of schizophrenic patients.
149-1	21989-21998	Including	_	
149-2	21999-22000	8	_	
149-3	22001-22006	cases	_	
149-4	22007-22009	of	_	
149-5	22010-22016	normal	_	
149-6	22017-22023	people	_	
149-7	22024-22027	and	_	
149-8	22028-22029	3	_	
149-9	22030-22035	cases	_	
149-10	22036-22038	of	_	
149-11	22039-22052	schizophrenic	_	
149-12	22053-22061	patients	_	
149-13	22061-22062	.	_	

#Text=The classification accuracy is 85.5%, specificity is 76.5%, sensitivity is 92.8%.
150-1	22063-22066	The	_	
150-2	22067-22081	classification	_	
150-3	22082-22090	accuracy	_	
150-4	22091-22093	is	_	
150-5	22094-22099	85.5%	_	
150-6	22099-22100	,	_	
150-7	22101-22112	specificity	_	
150-8	22113-22115	is	_	
150-9	22116-22121	76.5%	_	
150-10	22121-22122	,	_	
150-11	22123-22134	sensitivity	_	
150-12	22135-22137	is	_	
150-13	22138-22143	92.8%	_	
150-14	22143-22144	.	_	

#Text=Table 2 shows more details about the testing results on Oxy-Hb signal.
151-1	22145-22150	Table	_	
151-2	22150-22151	 	_	
151-3	22151-22152	2	_	
151-4	22153-22158	shows	_	
151-5	22159-22163	more	_	
151-6	22164-22171	details	_	
151-7	22172-22177	about	_	
151-8	22178-22181	the	_	
151-9	22182-22189	testing	_	
151-10	22190-22197	results	_	
151-11	22198-22200	on	_	
151-12	22201-22207	Oxy-Hb	_	
151-13	22208-22214	signal	_	
151-14	22214-22215	.	_	

#Text=For the Deoxy-Hb signal, there are also 11 misclassified cases.
152-1	22216-22219	For	_	
152-2	22220-22223	the	_	
152-3	22224-22232	Deoxy-Hb	_	
152-4	22233-22239	signal	_	
152-5	22239-22240	,	_	
152-6	22241-22246	there	_	
152-7	22247-22250	are	_	
152-8	22251-22255	also	_	
152-9	22256-22258	11	_	
152-10	22259-22272	misclassified	_	
152-11	22273-22278	cases	_	
152-12	22278-22279	.	_	

#Text=Including 8 cases of normal people and 3 cases of schizophrenic patients.
153-1	22280-22289	Including	_	
153-2	22290-22291	8	_	
153-3	22292-22297	cases	_	
153-4	22298-22300	of	_	
153-5	22301-22307	normal	_	
153-6	22308-22314	people	_	
153-7	22315-22318	and	_	
153-8	22319-22320	3	_	
153-9	22321-22326	cases	_	
153-10	22327-22329	of	_	
153-11	22330-22343	schizophrenic	_	
153-12	22344-22352	patients	_	
153-13	22352-22353	.	_	

#Text=The classification accuracy is 85.5%, specificity is 76.5%, sensitivity is 92.8%, the same as Oxy-Hb signal.
154-1	22354-22357	The	_	
154-2	22358-22372	classification	_	
154-3	22373-22381	accuracy	_	
154-4	22382-22384	is	_	
154-5	22385-22390	85.5%	_	
154-6	22390-22391	,	_	
154-7	22392-22403	specificity	_	
154-8	22404-22406	is	_	
154-9	22407-22412	76.5%	_	
154-10	22412-22413	,	_	
154-11	22414-22425	sensitivity	_	
154-12	22426-22428	is	_	
154-13	22429-22434	92.8%	_	
154-14	22434-22435	,	_	
154-15	22436-22439	the	_	
154-16	22440-22444	same	_	
154-17	22445-22447	as	_	
154-18	22448-22454	Oxy-Hb	_	
154-19	22455-22461	signal	_	
154-20	22461-22462	.	_	

#Text=For the total signal is shown in Table 3.
155-1	22463-22466	For	_	
155-2	22467-22470	the	_	
155-3	22471-22476	total	_	
155-4	22477-22483	signal	_	
155-5	22484-22486	is	_	
155-6	22487-22492	shown	_	
155-7	22493-22495	in	_	
155-8	22496-22501	Table	_	
155-9	22501-22502	 	_	
155-10	22502-22503	3	_	
155-11	22503-22504	.	_	

#Text=There are 15 misclassified cases.
156-1	22505-22510	There	_	
156-2	22511-22514	are	_	
156-3	22515-22517	15	_	
156-4	22518-22531	misclassified	_	
156-5	22532-22537	cases	_	
156-6	22537-22538	.	_	

#Text=Including 12 cases of normal people and 3 cases of schizophrenic patients.
157-1	22539-22548	Including	_	
157-2	22549-22551	12	_	
157-3	22552-22557	cases	_	
157-4	22558-22560	of	_	
157-5	22561-22567	normal	_	
157-6	22568-22574	people	_	
157-7	22575-22578	and	_	
157-8	22579-22580	3	_	
157-9	22581-22586	cases	_	
157-10	22587-22589	of	_	
157-11	22590-22603	schizophrenic	_	
157-12	22604-22612	patients	_	
157-13	22612-22613	.	_	

#Text=The classification accuracy is 80.3%, specificity is 64.7% and sensitivity is 92.8%.
158-1	22614-22617	The	_	
158-2	22618-22632	classification	_	
158-3	22633-22641	accuracy	_	
158-4	22642-22644	is	_	
158-5	22645-22650	80.3%	_	
158-6	22650-22651	,	_	
158-7	22652-22663	specificity	_	
158-8	22664-22666	is	_	
158-9	22667-22672	64.7%	_	
158-10	22673-22676	and	_	
158-11	22677-22688	sensitivity	_	
158-12	22689-22691	is	_	
158-13	22692-22697	92.8%	_	
158-14	22697-22698	.	_	

#Text=Here we choose Oxy-Hb signal to discriminate schizophrenic.
159-1	22699-22703	Here	_	
159-2	22704-22706	we	_	
159-3	22707-22713	choose	_	
159-4	22714-22720	Oxy-Hb	_	
159-5	22721-22727	signal	_	
159-6	22728-22730	to	_	
159-7	22731-22743	discriminate	_	
159-8	22744-22757	schizophrenic	_	
159-9	22757-22758	.	_	

#Text=This accuracy is especially satisfactory for the discrimination.
160-1	22759-22763	This	_	
160-2	22764-22772	accuracy	_	
160-3	22773-22775	is	_	
160-4	22776-22786	especially	_	
160-5	22787-22799	satisfactory	_	
160-6	22800-22803	for	_	
160-7	22804-22807	the	_	
160-8	22808-22822	discrimination	_	
160-9	22822-22823	.	_	

#Text=Conclusion
#Text=Our study demonstrated that the designed task is an effective experimental paradigm.
161-1	22827-22837	Conclusion	_	
161-2	22838-22841	Our	_	
161-3	22842-22847	study	_	
161-4	22848-22860	demonstrated	_	
161-5	22861-22865	that	_	
161-6	22866-22869	the	_	
161-7	22870-22878	designed	_	
161-8	22879-22883	task	_	
161-9	22884-22886	is	_	
161-10	22887-22889	an	_	
161-11	22890-22899	effective	_	
161-12	22900-22912	experimental	_	
161-13	22913-22921	paradigm	_	
161-14	22921-22922	.	_	

#Text=Compared with healthy controls, the multichannel fNIRS results on the sample confirmed that schizophrenia patients in the Chinese population had significant lower brain activation over the prefrontal cortex and superior temporal cortex.
162-1	22923-22931	Compared	_	
162-2	22932-22936	with	_	
162-3	22937-22944	healthy	_	
162-4	22945-22953	controls	_	
162-5	22953-22954	,	_	
162-6	22955-22958	the	_	
162-7	22959-22971	multichannel	_	
162-8	22972-22977	fNIRS	_	
162-9	22978-22985	results	_	
162-10	22986-22988	on	_	
162-11	22989-22992	the	_	
162-12	22993-22999	sample	_	
162-13	23000-23009	confirmed	_	
162-14	23010-23014	that	_	
162-15	23015-23028	schizophrenia	_	
162-16	23029-23037	patients	_	
162-17	23038-23040	in	_	
162-18	23041-23044	the	_	
162-19	23045-23052	Chinese	_	
162-20	23053-23063	population	_	
162-21	23064-23067	had	_	
162-22	23068-23079	significant	_	
162-23	23080-23085	lower	_	
162-24	23086-23091	brain	_	
162-25	23092-23102	activation	_	
162-26	23103-23107	over	_	
162-27	23108-23111	the	_	
162-28	23112-23122	prefrontal	_	
162-29	23123-23129	cortex	_	
162-30	23130-23133	and	_	
162-31	23134-23142	superior	_	
162-32	23143-23151	temporal	_	
162-33	23152-23158	cortex	_	
162-34	23158-23159	.	_	

#Text=Finnally, we achieved a considerable overall classification accuracy of 85.5% (65/76) using the SVM classifier and CBNA based feature selection on the oxy-Hb signal.
163-1	23160-23168	Finnally	_	
163-2	23168-23169	,	_	
163-3	23170-23172	we	_	
163-4	23173-23181	achieved	_	
163-5	23182-23183	a	_	
163-6	23184-23196	considerable	_	
163-7	23197-23204	overall	_	
163-8	23205-23219	classification	_	
163-9	23220-23228	accuracy	_	
163-10	23229-23231	of	_	
163-11	23232-23237	85.5%	_	
163-12	23238-23239	(	_	
163-13	23239-23241	65	_	
163-14	23241-23242	/	_	
163-15	23242-23244	76	_	
163-16	23244-23245	)	_	
163-17	23246-23251	using	_	
163-18	23252-23255	the	_	
163-19	23256-23259	SVM	_	
163-20	23260-23270	classifier	_	
163-21	23271-23274	and	_	
163-22	23275-23279	CBNA	_	
163-23	23280-23285	based	_	
163-24	23286-23293	feature	_	
163-25	23294-23303	selection	_	
163-26	23304-23306	on	_	
163-27	23307-23310	the	_	
163-28	23311-23317	oxy-Hb	_	
163-29	23318-23324	signal	_	
163-30	23324-23325	.	_	

#Text=Thus, SVM had the good classification performance especially after performing the CBNA based feature selection.
164-1	23326-23330	Thus	_	
164-2	23330-23331	,	_	
164-3	23332-23335	SVM	_	
164-4	23336-23339	had	_	
164-5	23340-23343	the	_	
164-6	23344-23348	good	_	
164-7	23349-23363	classification	_	
164-8	23364-23375	performance	_	
164-9	23376-23386	especially	_	
164-10	23387-23392	after	_	
164-11	23393-23403	performing	_	
164-12	23404-23407	the	_	
164-13	23408-23412	CBNA	_	
164-14	23413-23418	based	_	
164-15	23419-23426	feature	_	
164-16	23427-23436	selection	_	
164-17	23436-23437	.	_	

#Text=Our results illustrated that, by using the appropriate classification method, fNIRS represents a promising diagnostic tool to differentiate schizophrenia patients from healthy controls.
165-1	23438-23441	Our	_	
165-2	23442-23449	results	_	
165-3	23450-23461	illustrated	_	
165-4	23462-23466	that	_	
165-5	23466-23467	,	_	
165-6	23468-23470	by	_	
165-7	23471-23476	using	_	
165-8	23477-23480	the	_	
165-9	23481-23492	appropriate	_	
165-10	23493-23507	classification	_	
165-11	23508-23514	method	_	
165-12	23514-23515	,	_	
165-13	23516-23521	fNIRS	_	
165-14	23522-23532	represents	_	
165-15	23533-23534	a	_	
165-16	23535-23544	promising	_	
165-17	23545-23555	diagnostic	_	
165-18	23556-23560	tool	_	
165-19	23561-23563	to	_	
165-20	23564-23577	differentiate	_	
165-21	23578-23591	schizophrenia	_	
165-22	23592-23600	patients	_	
165-23	23601-23605	from	_	
165-24	23606-23613	healthy	_	
165-25	23614-23622	controls	_	
165-26	23622-23623	.	_	

#Text=Abbreviations
#Text=ACC
#Text=Accuracy
#Text=CBNA
#Text=Complex brain network analysis
#Text=Deoxy-Hb
#Text=Deoxygenated hemoglobin
#Text=FN
#Text=False negative
#Text=fNIRS
#Text=Functional near-infrared spectroscopy
#Text=FP
#Text=False positive
#Text=LN
#Text=Letter-number
#Text=OSH
#Text=Optimal separating hyperplane
#Text=Oxy-Hb
#Text=Oxygenated hemoglobin
#Text=SVM
#Text=Support vector machine
#Text=TP
#Text=True positive
#Text=TN
#Text=True negative
#Text=TNR
#Text=True negative rate
#Text=VFT
#Text=Verbal fluency test
#Text=References
#Text=Psychiatric comorbidities and schizophrenia
#Text=Functional near-infrared optical imaging: utility and limitations in human brain mapping
#Text=Quantitative comparison of resting-state functional connectivity derived from fnirs and fmri: A simultaneous recording study
#Text=Cortical correlates of auditory sensory gating: a simultaneous near-infrared spectroscopy event-related potential study
#Text=Prefrontal and premotor cortices are involved in adapting walking and running speed on the treadmill: an optical imaging study
#Text=Application of functional near-infrared spectroscopy in psychiatry
#Text=Discriminant analysis in schizophrenia and healthy subjects using prefrontal activation during frontal lobe tasks: a near-infrared spectroscopy
#Text=Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine model
#Text=Discriminant analysis of functional optical topography for schizophrenia diagnosis
#Text=Song H, Bogdan IIM, Wang S, et al.
166-1	23624-23637	Abbreviations	_	
166-2	23638-23641	ACC	_	
166-3	23642-23650	Accuracy	_	
166-4	23651-23655	CBNA	_	
166-5	23656-23663	Complex	_	
166-6	23664-23669	brain	_	
166-7	23670-23677	network	_	
166-8	23678-23686	analysis	_	
166-9	23687-23695	Deoxy-Hb	_	
166-10	23696-23708	Deoxygenated	_	
166-11	23709-23719	hemoglobin	_	
166-12	23720-23722	FN	_	
166-13	23723-23728	False	_	
166-14	23729-23737	negative	_	
166-15	23738-23743	fNIRS	_	
166-16	23744-23754	Functional	_	
166-17	23755-23768	near-infrared	_	
166-18	23769-23781	spectroscopy	_	
166-19	23782-23784	FP	_	
166-20	23785-23790	False	_	
166-21	23791-23799	positive	_	
166-22	23800-23802	LN	_	
166-23	23803-23816	Letter-number	_	
166-24	23817-23820	OSH	_	
166-25	23821-23828	Optimal	_	
166-26	23829-23839	separating	_	
166-27	23840-23850	hyperplane	_	
166-28	23851-23857	Oxy-Hb	_	
166-29	23858-23868	Oxygenated	_	
166-30	23869-23879	hemoglobin	_	
166-31	23880-23883	SVM	_	
166-32	23884-23891	Support	_	
166-33	23892-23898	vector	_	
166-34	23899-23906	machine	_	
166-35	23907-23909	TP	_	
166-36	23910-23914	True	_	
166-37	23915-23923	positive	_	
166-38	23924-23926	TN	_	
166-39	23927-23931	True	_	
166-40	23932-23940	negative	_	
166-41	23941-23944	TNR	_	
166-42	23945-23949	True	_	
166-43	23950-23958	negative	_	
166-44	23959-23963	rate	_	
166-45	23964-23967	VFT	_	
166-46	23968-23974	Verbal	_	
166-47	23975-23982	fluency	_	
166-48	23983-23987	test	_	
166-49	23988-23998	References	_	
166-50	23999-24010	Psychiatric	_	
166-51	24011-24024	comorbidities	_	
166-52	24025-24028	and	_	
166-53	24029-24042	schizophrenia	_	
166-54	24043-24053	Functional	_	
166-55	24054-24067	near-infrared	_	
166-56	24068-24075	optical	_	
166-57	24076-24083	imaging	_	
166-58	24083-24084	:	_	
166-59	24085-24092	utility	_	
166-60	24093-24096	and	_	
166-61	24097-24108	limitations	_	
166-62	24109-24111	in	_	
166-63	24112-24117	human	_	
166-64	24118-24123	brain	_	
166-65	24124-24131	mapping	_	
166-66	24132-24144	Quantitative	_	
166-67	24145-24155	comparison	_	
166-68	24156-24158	of	_	
166-69	24159-24172	resting-state	_	
166-70	24173-24183	functional	_	
166-71	24184-24196	connectivity	_	
166-72	24197-24204	derived	_	
166-73	24205-24209	from	_	
166-74	24210-24215	fnirs	_	
166-75	24216-24219	and	_	
166-76	24220-24224	fmri	_	
166-77	24224-24225	:	_	
166-78	24226-24227	A	_	
166-79	24228-24240	simultaneous	_	
166-80	24241-24250	recording	_	
166-81	24251-24256	study	_	
166-82	24257-24265	Cortical	_	
166-83	24266-24276	correlates	_	
166-84	24277-24279	of	_	
166-85	24280-24288	auditory	_	
166-86	24289-24296	sensory	_	
166-87	24297-24303	gating	_	
166-88	24303-24304	:	_	
166-89	24305-24306	a	_	
166-90	24307-24319	simultaneous	_	
166-91	24320-24333	near-infrared	_	
166-92	24334-24346	spectroscopy	_	
166-93	24347-24360	event-related	_	
166-94	24361-24370	potential	_	
166-95	24371-24376	study	_	
166-96	24377-24387	Prefrontal	_	
166-97	24388-24391	and	_	
166-98	24392-24400	premotor	_	
166-99	24401-24409	cortices	_	
166-100	24410-24413	are	_	
166-101	24414-24422	involved	_	
166-102	24423-24425	in	_	
166-103	24426-24434	adapting	_	
166-104	24435-24442	walking	_	
166-105	24443-24446	and	_	
166-106	24447-24454	running	_	
166-107	24455-24460	speed	_	
166-108	24461-24463	on	_	
166-109	24464-24467	the	_	
166-110	24468-24477	treadmill	_	
166-111	24477-24478	:	_	
166-112	24479-24481	an	_	
166-113	24482-24489	optical	_	
166-114	24490-24497	imaging	_	
166-115	24498-24503	study	_	
166-116	24504-24515	Application	_	
166-117	24516-24518	of	_	
166-118	24519-24529	functional	_	
166-119	24530-24543	near-infrared	_	
166-120	24544-24556	spectroscopy	_	
166-121	24557-24559	in	_	
166-122	24560-24570	psychiatry	_	
166-123	24571-24583	Discriminant	_	
166-124	24584-24592	analysis	_	
166-125	24593-24595	in	_	
166-126	24596-24609	schizophrenia	_	
166-127	24610-24613	and	_	
166-128	24614-24621	healthy	_	
166-129	24622-24630	subjects	_	
166-130	24631-24636	using	_	
166-131	24637-24647	prefrontal	_	
166-132	24648-24658	activation	_	
166-133	24659-24665	during	_	
166-134	24666-24673	frontal	_	
166-135	24674-24678	lobe	_	
166-136	24679-24684	tasks	_	
166-137	24684-24685	:	_	
166-138	24686-24687	a	_	
166-139	24688-24701	near-infrared	_	
166-140	24702-24714	spectroscopy	_	
166-141	24715-24725	Predictors	_	
166-142	24726-24728	of	_	
166-143	24729-24742	schizophrenia	_	
166-144	24743-24751	spectrum	_	
166-145	24752-24761	disorders	_	
166-146	24762-24764	in	_	
166-147	24765-24776	early-onset	_	
166-148	24777-24782	first	_	
166-149	24783-24791	episodes	_	
166-150	24792-24794	of	_	
166-151	24795-24804	psychosis	_	
166-152	24804-24805	:	_	
166-153	24806-24807	a	_	
166-154	24808-24815	support	_	
166-155	24816-24822	vector	_	
166-156	24823-24830	machine	_	
166-157	24831-24836	model	_	
166-158	24837-24849	Discriminant	_	
166-159	24850-24858	analysis	_	
166-160	24859-24861	of	_	
166-161	24862-24872	functional	_	
166-162	24873-24880	optical	_	
166-163	24881-24891	topography	_	
166-164	24892-24895	for	_	
166-165	24896-24909	schizophrenia	_	
166-166	24910-24919	diagnosis	_	
166-167	24920-24924	Song	_	
166-168	24925-24926	H	_	
166-169	24926-24927	,	_	
166-170	24928-24934	Bogdan	_	
166-171	24935-24938	IIM	_	
166-172	24938-24939	,	_	
166-173	24940-24944	Wang	_	
166-174	24945-24946	S	_	
166-175	24946-24947	,	_	
166-176	24948-24950	et	_	
166-177	24951-24953	al	_	
166-178	24953-24954	.	_	

#Text=Automatic schizophrenia discrimination on fnirs by using pca and svm.
167-1	24955-24964	Automatic	_	
167-2	24965-24978	schizophrenia	_	
167-3	24979-24993	discrimination	_	
167-4	24994-24996	on	_	
167-5	24997-25002	fnirs	_	
167-6	25003-25005	by	_	
167-7	25006-25011	using	_	
167-8	25012-25015	pca	_	
167-9	25016-25019	and	_	
167-10	25020-25023	svm	_	
167-11	25023-25024	.	_	

#Text=IEEE Int Conf Bioinforma Biomed IEEE Comput Soc. 2016;:389–94.
168-1	25025-25029	IEEE	_	
168-2	25030-25033	Int	_	
168-3	25034-25038	Conf	_	
168-4	25039-25049	Bioinforma	_	
168-5	25050-25056	Biomed	_	
168-6	25057-25061	IEEE	_	
168-7	25062-25068	Comput	_	
168-8	25069-25072	Soc	_	
168-9	25072-25073	.	_	
168-10	25074-25078	2016	_	
168-11	25078-25079	;	_	
168-12	25079-25080	:	_	
168-13	25080-25083	389	_	
168-14	25083-25084	–	_	
168-15	25084-25086	94	_	
168-16	25086-25087	.	_	

#Text=Complex network measures of brain connectivity: uses and interpretations
#Text=The human connectome: a complex network
#Text=Identification of vulnerable lines in power grid based on complex network theory
#Text=Structural vulnerability analysis of large power grid based on complex network theory
#Text=Efficiency of functional brain networks and intellectual performance
#Text=Developmental changes in organization of structural brain networks
#Text=Diffusion tensor imaging
#Text=Accelerated diffusion spectrum imaging in the human brain using compressed sensing
#Text=Data mining with computational intelligence
#Text=Least squares support vector machine classifiers
#Text=Libsvm: a library for support vector machines
169-1	25088-25095	Complex	_	
169-2	25096-25103	network	_	
169-3	25104-25112	measures	_	
169-4	25113-25115	of	_	
169-5	25116-25121	brain	_	
169-6	25122-25134	connectivity	_	
169-7	25134-25135	:	_	
169-8	25136-25140	uses	_	
169-9	25141-25144	and	_	
169-10	25145-25160	interpretations	_	
169-11	25161-25164	The	_	
169-12	25165-25170	human	_	
169-13	25171-25181	connectome	_	
169-14	25181-25182	:	_	
169-15	25183-25184	a	_	
169-16	25185-25192	complex	_	
169-17	25193-25200	network	_	
169-18	25201-25215	Identification	_	
169-19	25216-25218	of	_	
169-20	25219-25229	vulnerable	_	
169-21	25230-25235	lines	_	
169-22	25236-25238	in	_	
169-23	25239-25244	power	_	
169-24	25245-25249	grid	_	
169-25	25250-25255	based	_	
169-26	25256-25258	on	_	
169-27	25259-25266	complex	_	
169-28	25267-25274	network	_	
169-29	25275-25281	theory	_	
169-30	25282-25292	Structural	_	
169-31	25293-25306	vulnerability	_	
169-32	25307-25315	analysis	_	
169-33	25316-25318	of	_	
169-34	25319-25324	large	_	
169-35	25325-25330	power	_	
169-36	25331-25335	grid	_	
169-37	25336-25341	based	_	
169-38	25342-25344	on	_	
169-39	25345-25352	complex	_	
169-40	25353-25360	network	_	
169-41	25361-25367	theory	_	
169-42	25368-25378	Efficiency	_	
169-43	25379-25381	of	_	
169-44	25382-25392	functional	_	
169-45	25393-25398	brain	_	
169-46	25399-25407	networks	_	
169-47	25408-25411	and	_	
169-48	25412-25424	intellectual	_	
169-49	25425-25436	performance	_	
169-50	25437-25450	Developmental	_	
169-51	25451-25458	changes	_	
169-52	25459-25461	in	_	
169-53	25462-25474	organization	_	
169-54	25475-25477	of	_	
169-55	25478-25488	structural	_	
169-56	25489-25494	brain	_	
169-57	25495-25503	networks	_	
169-58	25504-25513	Diffusion	_	
169-59	25514-25520	tensor	_	
169-60	25521-25528	imaging	_	
169-61	25529-25540	Accelerated	_	
169-62	25541-25550	diffusion	_	
169-63	25551-25559	spectrum	_	
169-64	25560-25567	imaging	_	
169-65	25568-25570	in	_	
169-66	25571-25574	the	_	
169-67	25575-25580	human	_	
169-68	25581-25586	brain	_	
169-69	25587-25592	using	_	
169-70	25593-25603	compressed	_	
169-71	25604-25611	sensing	_	
169-72	25612-25616	Data	_	
169-73	25617-25623	mining	_	
169-74	25624-25628	with	_	
169-75	25629-25642	computational	_	
169-76	25643-25655	intelligence	_	
169-77	25656-25661	Least	_	
169-78	25662-25669	squares	_	
169-79	25670-25677	support	_	
169-80	25678-25684	vector	_	
169-81	25685-25692	machine	_	
169-82	25693-25704	classifiers	_	
169-83	25705-25711	Libsvm	_	
169-84	25711-25712	:	_	
169-85	25713-25714	a	_	
169-86	25715-25722	library	_	
169-87	25723-25726	for	_	
169-88	25727-25734	support	_	
169-89	25735-25741	vector	_	
169-90	25742-25750	machines	_	
